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Abstract 
Systems biology looks for emergent system effects from large scale assemblies of molecules 
and data, for instance in the human platelets. However, the computational efforts in all 
steps before such insights are possible can hardly be under estimated. In practice this 
involves numerous programming tasks, the establishment of new database systems but as 
well their maintenance, curation and data validation. Furthermore, network insights are 
only possible if strong algorithms decipher the interactions, decoding the hidden system 
effects. This thesis and my work are all about these challenges. To answer this requirement, 
an integrated platelet network, PlateletWeb, was assembled from different sources and 
further analyzed for signaling in a systems biological manner including multilevel data 
integration and visualization. PlateletWeb is an integrated network database and was 
established by combining the data from recent platelet proteome and transcriptome (SAGE) 
studies. The information on protein-protein interactions and kinase-substrate relationships 
extracted from bioinformatical databases as well as published literature were added to this 
resource. Moreover, the mass spectrometry-based platelet phosphoproteome was 
combined with site-specific phosphorylation/ dephosphorylation information and then 
enhanced with data from Phosphosite and complemented by bioinformatical sequence 
analysis for site-specific kinase predictions. The number of catalogued platelet proteins was 
increased by over 80% as compared to the previous version. The integration of annotations 
on kinases, protein domains, transmembrane regions, Gene Ontology, disease associations 
and drug targets provides ample functional tools for platelet signaling analysis. The 
PlateletWeb resource provides a novel systems biological workbench for the analysis of 
platelet signaling in the functional context of protein networks. By comprehensive 
exploration, over 15000 phosphorylation sites were found, out of which 2500 have the 
corresponding kinase associations. The network motifs were also investigated in this 
anucleate cell and characterize signaling modules based on integrated information on 
phosphorylation and protein-protein interactions.  
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Furthermore, many algorithmic approaches have been introduced, including an exact 
approach (heinz) based on integer linear programming. At the same time, the concept of 
semantic similarities between two genes using Gene Ontology (GO) annotations has become 
an important basis for many analytical approaches in bioinformatics. Assuming that a 
higher number of semantically similar gene functional annotations reflect biologically more 
relevant interactions, an edge score was devised for functional network analysis. Bringing 
these two approaches together, the edge score, based on the GO similarity, and the node 
score, based on the expression of the proteins in the analyzed cell type (e.g. data from 
proteomic studies), the functional module as a maximum-scoring sub network in large 
protein-protein interaction networks was identified. This method was applied to various 
proteome datasets (different types of blood cells, embryonic stem cells) to identify protein 
modules that functionally characterize the respective cell type. This scalable method allows 
a smooth integration of data from various sources and retrieves biologically relevant 
signaling modules. 
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Zusammenfassung 
Systembiologie sucht nach Systemeffekten in großflächigen Anordnungen von Molekülen 
und Daten, beispielsweise in menschlichen Blutplättchen. Allerdings kann der 
Rechenaufwand in den Schritten, die für solche Einsichten nötig sind, kaum unterschätzt 
werden. In der Praxis umfasst dies zahlreiche Programmieraufgaben, die Einrichtung neuer 
Datenbanksysteme, sowie deren Wartung, aber auch die Pflege und Validierung der 
vorgehaltenen Daten. Zudem sind Netzwerkeinsichten nur möglich, wenn effiziente und 
gute Algorithmen für versteckte Systemeffekte oder auch codierende Wechselwirkungen 
entschlüsseln. Diese Dissertation und meine Arbeit sind auf diese Herausforderungen 
konzentriert.  
Um diese Anforderung zu erfüllen, wurde ein integriertes Thrombozytennetzwerk, 
PlateletWeb, aus verschiedenen Quellen zusammengestellt und weiterhin auf 
Signalverarbeitung und –weitergabe einschließlich mehrstufiger Datenintegration und 
Visualisierung systembiologisch analysiert. PlateletWeb ist eine integrierte 
Netzwerkdatenbank, die durch die Kombination von Daten aus den neuesten 
Thrombozyten Proteom und Transkriptom (SAGE) Studien etabliert wurde. Information 
über Protein-Protein-Wechselwirkungen und Kinase-Substrat-Paaren wurde aus 
bioinformatischen Datenbanken hinzugefügt, extrahierte Daten aus der veröffentlichten 
Literatur ergänzten dies weiter. Darüber hinaus wurde das Blutplättchen-Phosphoproteom 
aufgrund von Daten aus der Massenspektroskopie mit ortsspezifischen Phosphorylierungs-
/ Dephosphorylierungsdaten kombiniert. Ergänzt wurde dies um Daten aus der Datenbank 
Phosphosite und durch bioinformatische Sequenzanalyse unter Nutzung ortsspezifischer 
Kinasevorhersagen. Die Zahl der katalogisierten Thrombozytenproteine wurde im 
Vergleich mit der Vorversion von 2008 um mehr als 80% erhöht (beinahe Verdoppelung 
der Daten, insbesondere aber neue, zusätzliche Datenkategorien, z.B. über Pharmaka, 
Phosphorylierung, Gen-Ontologie, daneben auch weitere Validierung und Pflege der 
vorhandenen Daten). Die neue Integration von Annotationen für Kinasen, Proteindomänen, 
Transmembranregionen, Gene Ontology, Krankheitsbezüge und Azneimittelziele bietet 
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neue, mächtige Werkzeuge für die funktionelle und systembiologische Analyse von 
Thrombozytensignalwegen. Die PlateletWeb Datenbank liefert eine neuartige 
systembiologische Werkbank zur Analyse von medizinisch relevanten 
Blutplättchensignalen (z.B. Plättchenaktivierung bei Thrombose, Hämostase etc.) im 
funktionellen Zusammenhang von Proteinnetzwerken. Durch umfassende Untersuchungen  
wurden über 15000 Phosphorylierungsstellen identifiziert, von denen 2500 einer Kinase 
zugeordnet werden konnten. Netzwerkmotive wurden auch in diesen Zellen ohne Zellkern 
untersucht und neue und interessante Signalmodule charakterisiert. Dies war nur durch die 
integrierte Information über Phosphorylierung und Protein-Protein-Wechselwirkungen 
möglich. 
Darüber hinaus wurden zahlreiche algorithmische Ansätze verwand, darunter ein exakter 
Ansatz zur Bayesschen Analyse von Interaktionsnetzwerken (Heinz) basierend auf linearer 
Integer-Programmierung. Gleichzeitig hat sich unser Konzept der semantischen 
Ähnlichkeiten zwischen zwei Genen basiert auf Gene Ontology (GO) Annotationen etabliert 
und ist eine wichtige Grundlage für viele analytische Ansätze in der Bioinformatik 
geworden. Unter der Annahme, dass eine höhere Anzahl von semantisch ähnlichen 
funktionellen Genannotationen biologisch relevantere Interaktionen reflektieren, wurde 
eine Bewertung der Kanten für funktionelle Netzwerkanalyse entwickelt.  
Die Kombination beider Ansäte, die Kantenbewertung, basierend auf der GO-Ähnlichkeit 
und die Netzknotenbewertung bezogen auf die Expression der Proteine ermöglichte in den 
analysierten Zelltypen (unter Nutzung von Daten z.B. aus Proteomstudien) die 
Identifizierung funktioneller Module als maximal bewertete Subnetzwerke in großen 
Proteinnetzwerken. Dieses Verfahren wurde an verschiedenen Proteomdatensätzen 
getestet (verschiedene Arten von Blutzellen, embryonale Stammzellen), um Proteinmodule 
zu identifizieren, die funktionell den jeweiligen Zelltyp charakterisieren. Weitere Ansätze 
der Methode erfassen die Analyse von quantitativen Phosphoproteom-Daten zur 
Identifizierung des Signalflusses in einem Kinase-Substrat Netzwerk. Diese skalierbaren 
Ansätze ermöglichen eine reibungslose Integration von Daten aus verschiedenen Quellen 
und liefern biologisch relevante Signalmodule. 
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1 Introduction  
Understanding the systems biological background of cellular processes is crucial for 
instance, identifying potential new biomarkers in human diseases. Genomic and proteomic 
data were generated in recent years by new tools and technologies. The focus is to integrate 
the information from multiple sources and manage the data with high reliability. The 
integrated data should have a backward tracking which would help identify every protein’s 
identification evidence and its functional information. This ever increasing number of 
proteomic and phosphoproteomic data generated by mass spectrometry calls for new 
strategies in data organization, representation and analysis.  
A cell type of particular interest is the blood platelet for its role in thrombosis and 
hemostasis and cardiovascular disease, which is still the major cause of all deaths.  Platelets 
(also called as thrombocytes) are small, irregularly shaped clear cell fragments which do 
not have a nucleus. The average life span is around 5 to 9 days. They circulate in the blood 
freely, if the number of platelets is too low, then this might result in excessive bleeding. 
However, if the platelet count is too high, blood clots can form and cause serious disease 
such as stroke or active heart failure.  Platelets thus play a key role in hemostasis and 
represent a central target for research in many pathophysiological processes, including 
cardiovascular diseases, inflammatory processes and metastasis (Varga-Szabo, Pleines et al. 
2008).  
In this thesis project, an integrated platelet interactome was assembled from multiple 
sources based on the manually curated protein data and the interactions between each of 
them. This platelet interactome could contain keys to solving the exact mechanisms of 
platelet activation and aggregation. Understanding the underlying mechanisms of platelet 
activation could hold the answer to new treatments and potential drug targets. Also, 
platelets are important anucleate cells where only posttranscriptional regulation is 
possible. A tight regulation of protein interactions is needed to ensure proper signaling. A 
thorough analysis of the platelet proteome and interactome provides a better 
understanding of signaling principles in anucleate cells. 
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A huge amount of mass spectrometry data on platelet proteins has been accumulated in 
recent years. However, a platform to combine both the phosphorylation and interaction 
information of these proteins is missing. The PlateletWeb is developed in order to 
overcome this factor and thus is the resource where the complete information about the 
platelet proteins was easily accessible. Furthermore, the integration of various data sources 
proves useful for a complex systems biological analysis of a given cell system. The proteome 
and transcriptome information on platelet proteins was combined along with 
phosphorylation and interaction data, thereby assembling a human platelet interactome 
and phosphoproteome containing platelet kinases and phosphorylations from literature 
and experimental sources. Kinase predictions for experimentally validated phosphosites 
were also included in the network (Linding, Jensen et al. 2007; Miller, Jensen et al. 2008). The 
newly created interactome was complemented by drug target information, disease 
associations, gene ontology annotation and KEGG pathway data allowing a more thorough 
analysis of platelet signaling. Finally, an integrated network of human platelets was 
established covering the proteome, phosphoproteome and transcriptome based on data 
from mass-spectrometry studies, public databases and literature research as described in 
Materials and Methods. Careful annotation resulted in a set of 5025 platelet proteins with 
evidence on either proteome or transcriptome level. 
Additional to this, in order to make the PlateletWeb a complete resource for platelet 
information, the data from DrugBank and KEGG were included. The drug database 
associated with the protein along with the genetic diseases provides a simple 
understanding of various levels of the protein information otherwise a tedious task to 
investigate. The KEGG pathways and the KEGG orthology were also provided focusing 
basically on the platelet proteins. Furthermore the transmembrane domain predictions, the 
protein characteristics, the Gene ontology information etc. on each of the platelet protein 
would make the PlateletWeb resource, a complete systems biological workbench providing 
an unmatched information about the platelets at one single place. 
Based on this information a study on other cell types was initiated to investigate the role of 
similar proteins and similar pathways in multiple species. An interactome of mouse 
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proteins was established and this was then mapped to the human proteins in order to find 
the orthologs and homologs of the proteins. Similar to the PlateletWeb database (Boyanova, 
Nilla et al. 2012), complete protein information was also added to the mouse database. A 
first draft of information was initiated, which forms the basis of a mouse platelet database 
to be published later. Furthermore, it can be updated to many other species and look for the 
protein of interest from multiple aspects.  
Additionally, the complete cell type analysis was made possible using the heinz algorithm 
included with the GOSim analysis. I could make the best use of the well curated Gene 
Ontology information and impute it into the heinz algorithm to quantify the proteins and 
their interactions. This helped to retrieve networks which are of high biological relevance. 
The complete analysis requires a higher computational details and insights with 
comparatively a higher challenge on the algorithm preparation. This GOSim algorithm 
design is mainly focus on the key aspect of it working with any sample proteins that are 
identified in any proteomic study.    
Furthermore, the motif analysis was performed to see the network patterns with in the 
constructed network of platelet interactome and identify the enrichment of a specific sub 
graphs with in the network. This was helped to identify the key switches in the network 
module and there by interpreting the information from the statistical overview.  
The available gene ontology information provided for all the proteins would help in 
understanding the protein in terms of their biological process, their molecular functionality 
and the place in the cell where it is located in the human readable format. This information 
is taken from the GO consortium and assembled to the platelet proteins. The gene 
enrichment analysis when performed, this human readable gene ontology would provide 
first insights on what the protein cluster does.  
The interaction between two proteins is specified in multiple ways; however, the 
quantification of the relation between two proteins would be a further step in achieving the 
similar clusters of proteins which perform a similar task. This quantification is performed 
by taking the gene ontology information between two proteins which are interacting 
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between each other and then checking for the semantic similarity between them and there 
after quantifying it. This would help to extract and understand the modules from the 
complete network of proteins which are specific to a certain criteria. A complete testing was 
performed by taking already existing modules (to cross check the validity of the extracted 
modules) and also by trying to figure out the new modules in different proteins identified in 
multiple samples.  
The quantitative and qualitative analysis which was carried out further helped to get the 
insights of the proteins which are otherwise might be overlooked.  
Thus PlateletWeb is the key resource for understanding, analyzing and predominantly a 
highly capable source of information about the platelet proteins giving the complete insight 
of each protein individually as well as the role of protein within a specific network module 
and the role of the cluster of proteins as a whole. Thus the PlateletWeb could be rightly 
termed as the “Systems biological workbench”. 
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2 Materials and Methods 
2.1 Proteomic databases 
The information about the platelet proteins, their interactions, phosphorylations, kinase 
information, drugs, genetic diseases information along with the gene ontology information 
is taken from multiple databases. The main source of information was the proteomic 
databases; the main focus is on the manually curated data, which would provide with the 




The Human Protein Reference Database is a database of manually curated proteomic data 
focusing mainly on human proteins. This database was initially assembled in 2003 with 
notable updates there on (Peri, Navarro et al. 2003). This database contains relatively a 
small set of 2,750 proteins and 25,050 literature references. The current version (HPRD 
release 9) (Keshava Prasad, Goel et al. 2009) contains over 30,000 proteins, with more than 
40,000 protein-protein interactions and over 90,000 post translational modifications. These 
statistics are obtained after careful annotations performed by biologists based on literature 
analysis of more than 450,000 PubMed links. Data is manually curated and no text mining 
algorithms are used. This sophisticated process ensures a very high quality of protein data 
coming from published articles.  
 
 Other databases 2.1.2
Information on human proteins and their interactions were downloaded from Entrez gene 
Database (NCBI)(Maglott, Ostell et al. 2007). NCBI provides a unique identifier called Entrez 
gene identifier (also called GeneID) where every gene is assigned a unique number. This 
ensures a proper cross link between multiple databases there by not repeating the same 
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gene twice even though taken from multiple sources. All proteins in the complete 
PlateletWeb database are identified uniquely on the basis of gene identifiers. 
 
 Individual Platelet Studies 2.1.3
The Platelet proteome catalogue was first defined by Dittrich et al (Dittrich, Birschmann et 
al. 2008) which includes an assembly of a comprehensive proteome and transcriptome 
database of human platelets. A model of the platelet interactome was later created with the 
platelet proteins. Based on this catalog of the platelet proteome, further data from various 
mass spectrometry studies published over the last 10 years have been assembled. Most of 
these studies are mainly focusing on the unfractionated platelets, specific platelet 
subcompartments including the plasma membrane, secretome and microparticles. 
Additionally, a previously performed Serial Analysis of Gene Expression (SAGE) study of 
human platelets was included. Also literature curated information was extracted from the 
NCBI GeneRifs (Maglott, Ostell et al. 2007) and were filtered for new platelet proteins. This 
comprehensive set of platelet proteins from multiple sources resulted in 5025platelet 
proteins. 
 
 Kinases and Phosphatases 2.1.4
A comprehensive list of human kinases were extracted from Manning et al (Manning, Whyte 
et al. 2002) and used for reference and validation of the HPRD phosphorylation data.  A 
kinase is a type of enzyme that transfers phosphate groups from high-energy donor 
molecules, such as ATP to specific substrates. This process is called phosphorylation and is 
important to identify the dynamics in the protein network regulation. All kinases were 
mapped to the human kinome tree created by Linding et al (Miller, Jensen et al. 2008) and 
visualized using the interactive online tool Tree Of Life (Letunic and Bork 2007). The 
catalogue of human phosphatases was acquired from the Human Protein Phosphatases PCR 
Array (Quiagen; 82 phosphatases) and the assembly of protein tyrosine phosphatases in the 
human genome (Alonso, Sasin et al. 2004) (103 phosphatases). The rest of the phosphatases 
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were added by manual search in the PlateletWeb for proteins with the term “protein 
phosphatases” in their description. The total number of human protein phosphatases adds 
up to 191 (phosphatases associated with a substrate: 39, platelet phosphatases: 73, platelet 
phosphatases with a substrate: 24).  
 
2.2 Protein-protein interactions (PPI) 
A considerable number of databases came into existence in the recent past focusing mainly 
on the protein-protein interactions, many of which are emphasizing on more than one 
species (Wang, Nath et al. 1999; Goddard, Ladds et al. 2006; Stark, Breitkreutz et al. 2006; 
Stark, Breitkreutz et al. 2011) give a few citations here: BioGrid, BIND and all the rest). The 
core idea of PlateletWeb is to create a network of human platelet proteins for detailed 
analysis on a single and multiple protein level. In order to accomplish this, the information 
from multiple databases was taken into consideration. The manually curated human 
protein-protein interactions were extracted from the Human Proteome Reference Database 
(HPRD) (version 9.0, 04/2010) (Keshava Prasad, Goel et al. 2009), which contains 39,194 
simple binary PPIs and 93,710 post-translational modifications. The post-translational 
modifications were also considered for the interactions list, as the modification itself is 
possible only if there exist an interaction between the proteins. Information about the type 
of experiment, in which the interaction was found, is also presented with each of the 
interaction.  Two proteins are considered to interact in vivo when the interaction was 
detected in a mammalian cell at the time of experiment. If it could not be concluded in the 
context of mammalian cells, it was considered in vitro. The third type of experiment is the 
Yeast 2-hybrid which describes interactions only detected in a yeast cell after performing 
this type of experiment. These can be technically termed as in vivo, but were annotated 
specifically as Y2H in order to identify the false positives interactions, if any. HPRD also 
includes data from Biological General Repository for Interaction Datasets (BioGrid) (Stark, 
Breitkreutz et al. 2011) and Biomolecular Interaction Network Database (BIND) (Alfarano, 
Andrade et al. 2005). Each interaction is also marked with its interaction sources thus 
helping to trace back to its source study.   
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The data was downloaded from the HPRD server in the FLAT file format. This file was then 
parsed using the Perl program and created as a table in the MySQL database. With the help 
of this structured query language, it was possible to remove the duplicate interactions and 
maintain the data in a definite order. The HPRD provides its proteins with a unique 
identifier called HPRD Id. The Entrez gene identifiers were them mapped to maintain 
consistency and ease of use. 
Another database that was taken into consideration with a particular interest is 
Phosphosite (accessed 01/2011) (Hornbeck, Chabra et al. 2004). Phosphosite is a systems 
biological resource which provides information about the protein post translational 
modifications. The database is manually curated and provided over 3000 protein 
translational modifications many of which are additional to the ones listed in the HPRD 
database. Additionally, an additional set of post translational modifications (both 
phosphorylations and dephosphorylations) on Serine (S) Threonine (T) and Tyrosine (Y) 
phosphorylations were included as a table in MySQL.  
A set of phosphorylations were also complemented by kinase predictions for platelet-
specific phosphoproteome data (Zahedi, Lewandrowski et al. 2008) using the NetworKIN 
algorithm (Linding, Jensen et al. 2007; Miller, Jensen et al. 2008). NetworKIN is a method for 
predicting in vivo kinase-substrate relationships. This algorithm combines two different 
approaches for phosphorylation prediction  - consensus sequence motif search and protein 
association networks (a network context of kinase and phosphoproteins which makes up to 
60-80% of computational capability to assign in vivo substrate specificity) in order to 
generate a full, realistic and statistically more probable prediction of the involved kinase. 
An online website was provided to predict the kinase substrate relationships 
(http://networkin.info/version_2_0/search.php). Results from experimental mass 
spectrometry analysis with determined phosphorylation sites were inserted into the 
website’s search functionality, which predicts the kinase responsible for a specific 
phosphorylation. Two different scores (a motif score and a context score) are calculated for 
each algorithm and presented in the final results. The predicted kinase substrate 
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relationships were also taken into consideration as additional information into the PPI 
network.  
In total, the complete human PPI network contains 54,218 simple interactions, 4,406 
phosphorylation events and 135 dephosphorylation events between 10,916 human 
proteins. 
 
2.3 Network motif analysis 
Networks are complex structures which are defined by nodes and interconnected edges. 
These networks carry a pattern which when recognized could provide an in-depth of 
network regulation and signaling. To unravel these networks, Milo et al (Milo, Shen-Orr et al. 
2002) defined the term “Network Motifs”. These network motifs are the patterns occurring 
in the complex network with numbers higher than those in the randomized networks.  
The Mfinder Version 1.2 software was used in order to enumerate the specific network 
motifs in the interactome and phosphoproteome network. The enrichment of a specific 
motif within the network is thereby calculated and helps to investigate various platelet 
signaling pathways. 
The software Mfinder Version 1.2(Milo, Shen-Orr et al. 2002; Kashtan, Itzkovitz et al. 2004) 
was used for detection of specific predefined(Zaidel-Bar, Itzkovitz et al. 2007) network 
motifs in the combined platelet interactome and phosphorylation network and analysis of 
overrepresentation as previously described by Milo et al(Milo, Shen-Orr et al. 2002). The 
algorithm identifies all n-node subgraphs in the input network. A set of randomized 
networks (100 randomizations were used in this analysis) was created by rewiring the 
edges but maintaining the same incoming and outgoing degree at each node. All 
randomized networks are examined for network patterns in the same way as the real 
network (=biological network) and the number of occurrences is calculated in each case. Z-
scores are obtained by subtracting the mean motif count in the randomized network from 
the observed count in the real network and subsequently dividing the result by the 
standard deviation of the randomized motif count (The Z-scores are defined with the 
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following formula: (Nreal – Nrand )/SD (Milo, Shen-Orr et al. 2002)). These final scores 
indicate the significance of enrichment for each motif in the real network. Subgraphs with 
high absolute Z-scores tend to be significantly enriched and are regarded as network 
motifs(Milo, Shen-Orr et al. 2002).  
 
2.4 Drugs and diseases 
Drug data were downloaded from DrugBank Version 3.0 (Knox, Law et al. 2011), which 
includes detailed information on drugs as well as on drug targets. The physical drug-target 
interactions are identified to get the overview on the possible indirect functional effects. 
The drugs are divided into multiple broad categories, mainly in approved and experimental 
groups. The database contains 4311 human drugs, which have a human drug target in the 
PlateletWeb knowledge base (approved, 1195; experimental, 3015) and act on 2106 distinct 
human proteins. There are 950 platelet proteins among these drug targets. Genetic disease 
information was extracted from HPRD and is available for 701 platelet proteins.  
 
2.5 KEGG Pathways 
KEGG (Kyoto Encyclopedia of Genes and Genomes) is a Pathway database. It is a collection 
of databases dealing with genomes, enzymatic pathways, and biological chemicals. The 
KEGG pathways were downloaded from the KEGG database (Release 57.0, January 1, 2011). 
However, from the middle of 2011, KEGG has switched to a subscription model and access 
via FTP is no longer free. Each pathway was termed individually to identify the platelet 
proteins. The platelet proteins identified in the pathways were visualized in the PlateletWeb 
knowledge base using the Advanced Pathway Painter v2.26. Enrichment analysis of 
pathways was performed using Fisher’s exact test comparing the number of platelet 
proteins in the pathway against the number of all platelet proteins annotated in KEGG 
pathways.  
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2.6 Gene Ontology 
In order to understand their biological role, genes are annotated by scientists using human 
language. This would help to understand the purpose of genes in a natural language format. 
However, when taking about the large-scale proteomics, there is a high probability that the 
genes are redundantly annotated with fair amount of ambiguity. In order to overcome this 
issue, the Gene Ontology consortium (Ashburner, Ball et al. 2000; 2008) has been developed 
which strives for a well-defined and structured functional assignment of genes. The GO 
terminology is arranged in a hierarchical way, which is also termed directed acyclic graph 
(DAG). As one goes down the hierarchy, terms become more specific. A parent GO term can 
be then sub divided into one or many different child terms, which describe a much more 
specific biological role than the general term.  
The GO is divided into three branches, Biological Process (BP), Molecular Function (MF) 
and Cellular Component (CC). The BP tree defines the overall process in which the gene 
product is involved, MF specifies the biochemical function and CC denotes the compartment 
or subcellular stricter where the gene product is located. As an example, the term 
“apoptosis” is identified in Biological Process, “kinase activity”, a molecular function and the 
term “nucleus” belongs to the ontology cellular component.  
Each biological function in the gene ontology is associated with a GO term, which is a unique 
identifier. Also, each of the go terms can be associated with one or more proteins and each 
of the proteins can be assigned to more than one go terms. The GO can be accessed as a 
downloadable file format or in the form of the MySQL table structure, where the required 
data can be easily queried. Alongside, there are a large number of tools available along with 
the GO which would help in elucidating the functional role of proteins.  
The vocabulary in GO has been constantly growing, with over 35,774 terms defined as on 
February 2012. Among them, the biological process has 21,964 terms defined; the 
molecular function has 9,238 and 2,960 in cellular component.  
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The whole database was downloaded and filtered for human proteins from GO and this was 
used for the functional profiling of the proteomic data. There are 4,728 platelet proteins 
annotated with a GO function, which accounts for a coverage of 94%. 
 
2.7 Semantic Similarity 
The concept of semantic similarity is mainly based on the very key notation, when there 
exist 2 nodes A and B and the main aim is to determine how similar these nodes are to each 
other. This can be quantified ranging between the values of 1 and 0. A value of 1 represents 
high similarity between the nodes and a value of 0 represents either no similarity or 
extremely low similarity.  
This concept was applied to proteins and their biological ontologies. The valuation for the 
semantic similarity between two genes is based on the Gene Ontology terms that are 
common between these genes.  The scores for the semantic similarity were initially 
calculated based on the method defined by Schlicker et al (Schlicker, Domingues et al. 2006) 
where the probability of the most informative common ancestor (MICA) is defined. The 
function of semantic similarity between “two terms” is defined as: 
(SimRel(C1,C2) = SimLin(C1,C2) x (1-CMICA)) (Schlicker, Domingues et al. 2006), 
where C1 and C2 represent two GO terms. This algorithm was further extended by Frohlich 
et al  (Frohlich, Speer et al. 2007) to calculate functional similarity between “two genes” 
(GOSim). The getGeneSim function in the GOSim package along with the funSimAvg as 
similarity measure (Schlicker, Domingues et al. 2006) determines the average of best 
matching GO term similarity for both genes. The semantic measurement was calculated for 
all the three ontologies (BP, MF and CC) on all interactions listed in the interactome. These 
results were then combined together for each interaction into one composite score using 
the BioNet package in R (Beisser, Klau et al. 2010). 
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2.8 Heinz algorithm extended with semantic similarity 
Recent experimental advancements are allowing the detection of the proteome which is 
either expressed in the cell or in a particular compartment of the cell. Once the proteins are 
identified, it’s a challenge to interpret them in the biological context. The analysis of a 
network obtained by combining data from expression profiling study of lymphoma patients 
with the comprehensive interactome data from HPRD was performed previously by Dittrich 
et al (Dittrich, Klau et al. 2008). In this prospect, the p-values are derived from the analysis 
of differential expression between two tumor subtypes as well from the analysis of survival 
data by cox regression for each node in the interaction network. The main idea is to identify 
functional modules in the PPI network, sharing common cellular functions. In order to 
achieve this, a maximally scoring network is devised along with the scoring of the nodes in 
the network to be identified. 
This identification of the functional modules in the network was extended by weighing the 
edges depending upon the semantic similarity of their nodes. If two genes are semantically 
similar to each other they would get a higher value close to or equal to 1 and if they are not 
semantically similar, they would get a value close to 0 or equal to 0. These scores were 
calculated using the “GOSim package” for all the three ontologies – BP, MF and CC. The 
scores were then converted into empirical p-values and using the aggregation statistics 
previously defined by Dittrich et al (Dittrich, Klau et al. 2008), which was based on 
distribution of the order statistics, a single p-value was obtained. Based on these aggregated 
p-values, a scoring function was defined which represents the p-values as a mixture of a 
noise and a signal component.  The scores obtained from this scoring function were termed 
“Edge Scores”. Once the edge scores were calculated, the nodes of interest (proteins 
identified in the sample) were scored by calculating the negative average of the scores of 
their connected edges. The rest of the nodes were given the average of all edge scores.  
The BioNet package (Beisser, Klau et al. 2010) provides an extensive framework for 
integrated network analysis using R and BioConductor. The methods for finding the optimal 
and suboptimal solutions were extensively used for finding the functional networks. 
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In order to identify the functional modules, an extensive usage of heavy induced graphs 
(heinz) was made. The algorithm to identify the optimal scoring subnetwork is based on the 
software dhea (district heating) from Ljubic et al. (Ljubic, Weiskircher et al. 2006). The 
program is developed in C++ to generate the optimal and suboptimal solutions. This is 
controlled over a Python script. The dhea code uses the commercial CPLEX license to 
calculate the suboptimal solutions. The dhea code and heinz python script are publicly 
available for academic and research purposes within the heinz (heaviest induced subgraph) 
package of the open source library, LiSA (http://www.planet-lisa.net). If the CPLEX license 
is not available, the maximum-scoring subnetwork can still be calculated with the included 
heuristic in the BioNet package (runFastHeinz). 
 
2.9 Phosphoproteomics (Quantitative analysis) 
Phosphoproteomics is one of the rapidly evolving fields in mass-spectrometry analysis. In 
contrast to previous methods which mainly rely on whole-protein data, this approach 
focuses on the analysis of cell-wide phosphorylation patterns. This integrated analysis 
combines protein-protein interaction (PPI) networks along with phosphoproteomic data to 
functionally describe signaling pathways and the change of information flow during various 
states of stimulation. Quantitative phosphoproteome data for node scoring in networks 
derived from PPI data along with the kinase-substrate relationships is used to understand 
this in the systems biological manner. Additional kinase information is integrated into the 
network as it is essential for understanding the regulatory mechanisms of protein signaling. 
The maximum-scoring subnetwork using an exact approach (heinz) is used to identify 
differentially phosphorylated signaling modules in cellular networks. This exact approach 
for searching biologically relevant functional modules has already been introduced in 
microarray analysis and is now extended to site-specific phosphoproteomics data. The 
algorithm in combination with human kinase-substrate relationships from in vivo and in 
vitro experiments on a dataset of differentially phosphorylated human embryonic stem cells 
(hESCs) (Rigbolt, Prokhorova et al. 2011) was used. With this approach, the analysis of 
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networks under various conditions (including time-series experiments) is carried out, 
thereby characterizing system states in a network context.  
A total of 6,521 proteins were identified in the original dataset (Rigbolt, Prokhorova et al. 
2011) using Stable isotope labeling by amino acids in cell culture (SILAC) method, of which 
5765 proteins were mapped in the PlateletWeb database along with 205 kinases. The site- 
specific phosphorylation changes were measures after application of non-controlled 
medium (NCM) 30 minutes, 1 hour, 6 hours and 24 hours after stimulation. 12,070 distinct 
peptides with 141 kinases acting on these phosphosites were identified. Of these, 539 
phosphosites and 281 proteins were associated with at least 1 kinase. The SILAC ratios 
were calculated in order to get the differential phosphorylation between the treated and the 
controlled cells. 
The SILAC ratios were then transformed into the site specific node scores and used the 
algorithm to obtain time-specific response modules of phosphorylation signaling during 
hESCs differentiation. 
 
2.10 Visualization and other tools  
TMHMM: Transmembrane domains have been predicted using the TMHMM Server, Version 
2.0 (Krogh, Larsson et al. 2001) yielding a total of 5,107 transmembrane proteins, of which 
1,158 are platelet proteins 
 
Cytoscape: Cytoscape is an open source platform for complex network analysis and 
visualization. It is a java based tool and can be run as standalone software on the local 
computer. Throughout the study, the visualization of the subnetworks is performed by 
Cytoscape version 2.6.3, unless specified. 
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Bingo Plugin: Bingo (Biological Network Gene Ontology Tool) is a plugin for Cytoscape. It 
helps to determine which Gene Ontology categories are statistically over or under 
represented in a set of genes. Gene enrichment analysis was performed by the BINGO plug-
in v2.44 of the network analysis software Cytoscape 2.8. For the full GO annotation 
comparison, all platelet proteins with a GO functional annotation in the network were 
considered (Biological Process (BP): 3,263; Molecular Function (MF): 3,412; Cellular 
Component (CC): 3,394 of total 5,025 platelet proteins). Statistically significant categories 
(P<0.0001) were selected according to their corrected p-values, using a hypergeometric 
test. Visualization of the BP, MF and CC results was performed for selected GO terms with 
less than 600 proteins. The top 25 GO terms were then used for visualization and colored 
according to the common parent with high information content in the hierarchical GO tree. 
  
R: R is a language for statistical computing and graphics. It is free software under the terms 
of GNU in the source code form. R was used vigorously throughout the project for multiple 
analyses after installing the required packages.  
 
Igraph: “igraph” is a free software package for creating and manipulating undirected and 
directed graphs. This package was used for the online visualization (on the PlateletWeb 
website) of networks on a chosen subset of proteins. This package can be used in multiple 
forms, for this work, R package was installed and used. 
 
MySQL: MySQL is a relational database management system and it’s a structured query 
language. The data taken from multiple sources were saved in the form of tables in the 
database and uniqueness was maintained for the gene identifiers.   
 
PHP/CSS YAML framework: The PlateletWeb website was designed using the PHP 
(Hypertext Preprocessor) with an extensive usage of CSS (Cascaded Style Sheets) and its 
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framework, YAML (Yet Another Multicolumn Layout). MySQL was used as the backend for 
the website. 
 
Perl: Parsing of sequences and flat files were performed using Perl (Practical Extraction 
and Reporting Language). 
 
Microsoft Office; Notepad++: Typesetting of manuscripts and periodical updates were 
saved in Microsoft Word and Notepad++. Additionally, the Microsoft Excel was used for a 
first overview of the processed data in the graphical formats.  
 
XAMPP: XAMPP (Cross platform, Apache, MySQL, PHP and Perl) is a free and open source 
cross platform webserver package. XAMPP is extensively used for the development version 
of the PlateletWeb knowledgebase and the PlateletWeb resource.  
 
  




Understanding the cellular mechanisms of platelet activation and their pharmacological 
modulation is of major interest in cardiovascular platelet research. A first step towards 
obtaining deeper insight into platelet signaling networks is to look at key molecular 
building blocks. Therefore, a multi-functional platelet network database (PlateletWeb) was 
established by collecting proteome data from large-scale proteome studies, well-curated 
protein databases, published literature as well as from transcriptome data (Dittrich, 
Birschmann et al. 2005; Dittrich, Birschmann et al. 2008). PlateletWeb provides a novel 
systems biology workbench for the analysis of platelet signaling in the functional context of 
integrated networks.  An integrated network database was established combining data 
from recent platelet proteome and transcriptome (SAGE) studies with information on 
protein-protein interactions and kinase substrate relationships extracted from 
bioinformatical databases as well as published literature. Moreover, mass spectrometry-
based platelet phosphoproteome was combined with site-specific phosphorylation / 
dephosphorylation information from the Human Protein Database (HPRD) and Phosphosite 
and complemented by bioinformatical sequence analysis for site-specific kinase predictions. 
The number of catalogued platelet proteins was increased by over 80% as compared to the 
previous version (Dittrich, Birschmann et al. 2008).  Integration of comprehensive 
annotations on kinases, protein domains, transmembrane regions, Gene Ontology, disease 
associations as well as drug targets provides ample functional tools for platelet signaling 
analysis. The resource is made available as PlateletWeb knowledgebase and this can be 
reached from the website http://plateletweb.bioapps.biozentrum.uni-
wuerzburg.de/plateletweb.php 
 
 Data sources 3.1.1
The PlateletWeb database is a highly scalable, reliable and up to date database, which has 
the tendency to expand easily with more information that comes in. My part in the study 
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was to make sure and implement this database with the huge consideration on various 
factors, for instance scalability, non-redundancy, consistency etc. In order to achieve this, 
the structure of the database should be consistent throughout and the addition of 
information from any source would not affect the already existing information. In order to 
achieve this, a careful analysis on the proteins from multiple sources was made and similar 
proteins from multiple databases are mapped to gain a highly reliable and sophisticated 
database which contains unique protein coming from multiple sources. The assembly of this 
information requires a high detailed overview on the source data that is being used. A 
careful annotation of each of these proteins is also required in some special cases where the 
protein in the source is wrongly annotated.  
Platelet proteome data was assembled from recent mass spectrometry studies of 
unfractionated platelets and specific platelet subcompartments. Platelet proteins were 
gathered from various studies including the latest proteomic whole cell and secretome 
analysis to ensure a complete set of new proteins. Additionally the data was taken from 
multiple data sources which have the human protein specific information. The information 
was combined and emphasis was given on the platelet proteins.  
Platelet proteome data have been collected manually from all available literature and 
proteomic databases and combined with transcriptome data (SAGE). It resulted in a set of 
5025 platelet proteins, including 22 major platelet datasets, creating a comprehensive and 
reliable backbone for platelet-specific information. 
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Figure 1 - Proteins extracted from literature and databases 
Different sources are compared in this Venn diagrams, e.g. 201 proteins are found by all three 
methods. The intersections and specific numbers show that the different sources are rather 
complementary then redundant. 
Proteins were categorized according to the cellular subcompartments from which they 
were isolated, which revealed that membranes and secretome are the most abundant 
fractions. Proteins were analyzed individually depending on the source of platelet 
information (proteome and transcriptome). The proteome group was in turn subdivided 
into proteome studies (large-scale proteomic analysis) and proteome databases 
(bioinformatic databases). The majority of proteins (3783 proteins, 75%) have been 
described on the proteome level, 14% (722 proteins) have additional evidence on the 
transcriptome level, and 25% (1242) of all platelet proteins have been detected exclusively 
on the mRNAlevel. 
A detailed analysis of the platelet protein sources was performed to identify the studies and 
fractions, from which the platelet proteins were extracted. The largest part of platelet 
proteins are coming from the meta database of mass spectrometry data GPMBD (citation). 
The transcriptome represents the second most abundant source of platelet information. 
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Interestingly, the membrane platelet proteome study by Lewandrowski et al contains the 
highest number of extracted platelet proteins in a single study. A complete list of platelet 
proteins along with their study and fraction is provided in the table below.  
 





GPMBD 2011 2064 whole platelet 
SAGE(Dittrich, Birschmann et al. 2006) 1964 whole platelet 
Lewandrowski 2009(Lewandrowski, Wortelkamp et al. 
2009) 
1269 membrane 
Piersma 2009(Piersma, Broxterman et al. 2009) 707 secretome 
Haudek 2009(Haudek, Slany et al. 2009) 671 whole platelet 
Martens 2005(Martens, Van Damme et al. 2005) 608 whole platelet 
Garcia 2005(Garcia, Smalley et al. 2005) 554 microparticles 
Uniprot 2009(2009) 538 undefined 
Wong 2009(Wong, McRedmond et al. 2009) 358 whole platelet 
Garcia 2004(García, Prabhakar et al. 2004) 305 whole platelet 
Moebius 2005(Moebius, Zahedi et al. 2005) 281 membrane 
Thon 2008(Thon, Schubert et al. 2008) 279 whole platelet 
Zahedi 2008(Zahedi, Lewandrowski et al. 2008) 277 phosphoproteo







HPRD(Keshava Prasad, Goel et al. 2009) 230 undefined 
Maynard 2007(Maynard, Heijnen et al. 2007) 206 alpha granules 
Coppinger 2004(Coppinger, Cagney et al. 2004) 182 secretome 
Guerrier 2007(Guerrier, Claverol et al. 2007) 176 whole platelet 
Coppinger 2007(Coppinger, Fitzgerald et al. 2007) 132 secretome 
GeneRIF 120 undefined 
Springer 2009(Springer, Miller et al. 2009) 119 whole platelet 
O'Neill 2002(O'Neill, Brock et al. 2002) 116 whole platelet 
Marcus 2000(Marcus, Immler et al. 2000) 109 whole platelet 
Garcia 2006(Garcia, Senis et al. 2006) 77 whole platelet 
Yu 2010(Yu, Leng et al. 2010) 77 whole platelet 
Thiele 2007(Thiele, Steil et al. 2007) 29 whole platelet 
Glenister 2008(Glenister, Payne et al. 2008) 16 whole platelet 
 
All platelet information sources are presented with the source of data, number of platelet 
proteins and the fraction from which the proteins were extracted. Each platelet protein was 
identified in at least one or several studies, this information was provided on the 
PlateletWeb website under “Platelet Evidence”. 
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Analysis indicates that whole platelet investigation is predominantly used in platelet 
proteomics. This resource helps in understand information about the complete platelet 
easily along with its interactions and phosphorylations with other platelet proteins as well 
as the human proteins.  Single compartment analysis such as membrane or microparticles is 
difficult to achieve due to technical limitations in extraction of specific platelets sub 
compartments. 
 
 PlateletWeb Statistics 3.1.2
The analysis on any of the databases reveals the amount of information it contains and this 
can be easily achieved by using the statistics. Additionally, the numbers would help to 
maintain the integrity in the complete network and it easily shows the flaws if for instance, 
some proteins or some interactions are falsely identified (false positives or false negatives). 
However, to gain the statistical analysis, it is required to have the complete database at 
hand and initiate the huge process on analyzing the network from multiple aspects. The 
assembly of the database is the key for the analysis. This analysis is of course of huge help 
when a new version of the same database is created, with new data or information and then 
comparisons reveals the insights which can otherwise be never detectable. Having 
meticulously assembled the different databases from multiple sources, the work achieved 
in this thesis now allows to easily complying with the up to date information on the human 
proteins, emphasizing on the human platelets.  
The complete human proteome with interactome information was compiled which revealed 
54,218 simple interactions with over 4400 phosphorylation events between 10,915 human 
proteins. Additionally 135 dephosphorylation events were included into this interactome. 
The table 2 below depicts the numbers showing the increase of interactome information 
when compared with the previous version from us (Dittrich, Birschmann et al. 2008). 
The comparison on the older to the latest version of PlateletWeb is important as it reveals 
the amount of data that was explored for this study along with the increased improvements 
in the platelet resources. The source of information was increased from a total of 6 
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proteomic studies to over 15 studies. Additionally, the data from the public databases like 
HPRD (Keshava Prasad, Goel et al. 2009), GPMDB and Uniprot, the transcriptomic database, 
SAGE (Dittrich, Birschmann et al. 2006) were taken and put together for the PlateletWeb.  
This would help to realize each of the platelet protein with its source as in which studies the 
protein is discovered as platelet, and in which databases this was as well defined. This 
complete analysis will help to classically consider the genuineness of the platelet protein.   
The number of interactions of the platelet proteins was increased from 2839 to an 
impeccable number of 58758 making it more than 20 times bigger interactome network. 
This was achieved by considering all the well-known interactions in the literature and the 
databases. Similarly, the number of proteins itself was increased from 3093 to 19813, a 
factor of 6. This huge numbers indicate a much bigger network of proteins with much 
improved dataset when compared to the previous version. 
This improved new version of PlateletWeb has a huge number phosphorylations and 
dephosphorylations, including the sites, the events and the kinase predictions in some 
cases. Additionally, each platelet protein was check to see if this is a phosphorylated kinase 
or protein alongside the complete protein information. This resource thus provides 
complete information on platelet proteins. The table 2 showcases the numbers that were 
increased form the older version to the present version of PlateletWeb database.  
 
Table 2 - Human Interactome statistics:  
 Study/Database PlateletWeb 2008 PlateletWeb 2012 
Total interactions 2839 58758 
Total proteins 3093 19813 
Platelet proteins 3093 5025 
Phosphorylation and Dephosphorylation events - 6243 
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 Study/Database PlateletWeb 2008 PlateletWeb 2012 
Total phosphorylation sites - 73734 
Total dephosphorylation events - 171 
Platelet phosphorylation events - 28800 
Platelet dephosphorylation events - 99 
Total phosphorylated proteins - 10441 
Total phosphorylated kinases - 461 
Platelet phosphorylated proteins - 3532 
Platelet phosphorylated kinases - 216 
 
The interactome was then used to check for its characteristics, and was also compared with 
the previous version of the platelet interactome network. This revealed an incredible 
increase in the platelet interactome (84.34%) which in turn enables to consider a high 
number of proteins for the statistical analysis. 
The size of the largest connected component has changed from 1365 (70.65%) to 3060 
(84.34%). This suggests the extremely good connectivity of the proteins with in the 
network. The network regulation can be investigated in detail because of this increase in 
the interaction and phosphorylation data.  
The number of singletons is another important aspect, which describes the reliability of this 
network. The number of singletons remained almost constant. Considering the fact of the 
increased number of platelet proteins, these singletons signify the extremely good 
connectivity of the platelet network.  The increase in connectivity also influences the 
average degree of nodes, which specifies the average number of interactions of each 
protein. This was improved from 2.951 to 6.771, a pretty higher connectivity of the platelet 
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network. Also, the maximum path length has decreased from 15 to 10 indicating a tight 
moduled network. 
 





Number of all nodes 1932 3628 
Number of Interactions 2851 13652 
Number of components 532 536 
Size of largest component 1365 3060 
Size of largest component (%) 70.65% 84.34% 
Singletons 503 510 
Singletons (%) 26.04% 14.06% 
Average degree 2.951 6.771 
Characteristic path length 4.972 3.917 
Maximal path length 15 10 
 
The proteins were then separated according to the residue and the numbers provide an 
overview of the distribution of Serine-and Threonine-phosphorylation sites in human 
platelets. Serine phosphorylations are predominant, followed by threonine and tyrosine 
phosphorylated residues. This tendency is found generally in all phosphorylation sites and 
specifically also in literature platelet sites. The experimentally-validated sites have a 
comparably low percentage of tyrosine phosphorylations (4.0%), which might be due to the 
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lack of tyrosine-specific antibodies. According to previous studies, tyrosine 
phosphorylations are often found on less abundant proteins and their detection is 
complicated due to the lower stability the phosphorylated tyrosine (Olsen, Blagoev et al. 
2006). 
 
Table 4 - Phosphorylation sites 
 S T Y 
Literature all sites 45195 15249 13277 
Literature platelet sites 16469 6180 6138 
Experimental all / platelet sites 441 72 21 
526 kinases were identified in the human proteome of which 229 were identified as platelet 
kinases. Additionally, the kinases substrate relations were calculated to determine how 
many platelet substrates have associated platelet and non-platelet kinases. When 
introducing a limitation of platelet kinases acting on platelet substrates, then the platelet 
kinases were reduced to 162 and the platelet substrates to 740. Association with a platelet 
kinase increases the chances of the phosphorylation to take place in platelets under normal 
biological conditions. Therefore, these phosphorylation events give strong indication for 
signaling regulation in the platelet when there is no experimental evidence available in 
literature for this cell type. 
 
Table 5 – Kinase substrate associations; Kinase acting on substrates 
 
PlateletWeb 2012 




Kinases on All substrates 329 
Kinases on Platelet substrates 268 
Platelet Kinases on All substrates 176 
Platelet Kinases on Platelet substrates 162 
 
Table 6 – Kinase substrate associations; Substrates targeted by kinases 
 PlateletWeb 2012 
Substrates targeted by Kinases 1801 
Platelet Substrates targeted by Kinases 810 
All Substrates targeted by Platelet Kinases 1614 
Platelet Substrates targeted by Platelet Kinases 740 
 
The Gene Ontology information is taken from the GO Consortium and all the human 
proteins were annotated in the PlateletWeb. The following table provides the statistics of 
Gene Ontology terms associated with the platelet proteins. 
 
Table 7 –Gene Ontology information associated with Platelet proteins   
 PlateletWeb 2012 
Total GO Terms with all human proteins annotated in PlateletWeb 13736 
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 PlateletWeb 2012 
Total GO Annotations with platelet proteins 10148 
Total proteins associated with GO Term 17546 
Platelet proteins associated with GO Term 4728 
 
Along with the functionality of each platelet protein, relevant information was added about 
its drug associations. Drug modulation is an important aspect in cell biology because it 
allows controlled tuning of various cell processes and often represents a first step in 
development of new therapies. The drug information is taken form DrugBank, and then 
mapped with the platelet proteins in the PlateletWeb resource, which revealed a high 
number of platelet drug targets. Almost half of the known human drugs (2706 out of 4311 
drugs) are targeting platelet proteins. The high amount of platelet drug targets indicates 
that drug discovery is focused on many proteins in the platelet cell and underlines the 
importance of platelets in clinical research.   
 
Table 8 – Drug Targets   
 PlateletWeb 2012 
Total Drug Targets 2106 
Platelet Drug Targets 950 
Total Drugs 4311 
Drugs acting on platelet proteins 2706 
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 Knowledgebase and the flow of information 3.1.3
The platelet data is accumulated from various sources using the techniques of data mining 
and manual curation. In order to investigate the biological insights of this data, a resource 
was created which helped to understand platelet signaling pathways. This resource is 
further extended to create a website (knowledgebase) for platelets as a platelet systems 
biological platform which was termed PlateletWeb. This knowledgebase combines and 
visualizes the most recent proteomic studies investigating platelet proteins and provides 
basis to a more comprehensive analysis of platelet-specific functions. Based on data from 
our resource gave a complete overview of platelet signaling, interactions, phosphorylation 
events and identified enrichment of platelet-specific pathways and functions.  The kinome 
and phosphoproteome were analyzed, followed by the introduction of drug options and 
network modulation. Furthermore, the physical information of the protein along with the 
Gene Ontology and KEGG pathway information was also visualized and made available in 
the knowledgebase. The platform allows a comprehensive and detailed analysis of the 
platelet not only on a single protein level but also on the scale of network regulation and 
functional association of signaling components. Alongside, the access of the information 
contained in the resource is made easy by creating multiple search functions which would 
help to extract the information easily and quickly from the knowledgebase.  
Assembling the database itself is one main aspect; however it is not finished without 
creating a proper graphical user interface to retrieve the right amount of information. The 
accessing of the information would require sophisticated website development to give the 
ease of use. This would make the database a user friendly resource which can be easily 
accessible from anywhere around the world. A first hand website is created for the previous 
version (Dittrich, Birschmann et al. 2008), which was extended to add the new information 
with a high significance on the platelet proteins.   
A detailed tutorial on the usage of the platform is presented in the supplemental Appendix 1 
(PlateletWeb user guide). 
The following flowchart depicts the way the key aspects of PlateletWeb knowledgebase and 
the way it helps to access the right data. The knowledgebase design is biased towards the 
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end user’s perspective. For instance, it is possible to get the complete details of the protein 
starting from the interactions, its phosphorylations, its site specific information, the 
physical properties etc., by just entering the name of the protein. Additionally, the similar 
names, which would give another chance to recheck the protein is also considered. Some 
proteins have alternative names and this presentation of similar proteins would help in 
order to get the information for the right protein. The complete protein description page, 
containing multiple sections, each of which, concentrating on a particular information of the 
protein can also be retrieved. This is a simple search which provides the ease of use and 
gets the information about the protein instantly.  
It is also possible to concentrate on a group of proteins with similar functionality or to 
extract a group of proteins which are, for instance, phosphorylating on the tyrosine residue. 
There is multiple simplified advanced search criteria were defined with in the 
knowledgebase which would give access to retrieve the set of proteins with similar 
classification. These proteins can be either searched from the point of view of the drug 
targets or the containing similar gene ontology term or at the lowest level having similar 
physical properties. A protein or group of proteins with similar attributes is retrieved in 
such cases and this can then be also visualized. For example, in the advanced search it is 
possible to extract platelet proteins with multiple similar features: having the same 
function (e.g. hemostasis) and protein domain (e.g. transmembrane domain TM) and 
phosphorylated on a tyrosine residue. This particular search yields three proteins with the 
predefined criteria: GP1BA, ITGB3 and PECAM-1. All three proteins are well-known platelet 
signaling modulators, playing a role in platelet activation using SH2 domain binding. 
Additionally, the information obtained at any instance, either at the level of similar proteins 
or the phosphorylations of a particular protein or even the description of the protein, they 
all can be printed. Apart from this, the download options enable to download specially the 
information about the sequences and the subnetworks that are visualized. The flow chart 
gives the pictorial representation of the complete work flow of the website.   
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Figure 2 – Flowchart of the PlateletWeb workbench. 
The query can be provided using simple search or advanced search. This provides the complete 
information about the protein(s) and it is also possible to download or print the result. 
 
Query Protein Advanced Search 
 
Search by: 
• Gene identifiers 
• Drug targets 
• Specific terms 
• Combinational search 
• Physical properties 
List of similar proteins 
Interaction and phosphorylation state 
Information about the protein 
 
• Source of detection for platelet proteins 
• Interaction and phosphorylation information 
• Visualization of sub networks 
• Gene ontology information 
• Drug / disease annotations 
• Transmembrane predictions 
• KEGG pathways emphasizing on platelet proteins 
• Summary and description of proteins 
• Protein domains and motifs 
• Protein physical characteristics 
Print / download information 
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The database is very useful to investigated interactions in the platelet. By choosing the 
protein name (e.g. VASP) an overview of the protein description, physical and biological 
properties and phosphorylations is revealed. In contrast, to find the interaction partners 
such as Abi1, a network view of the neighboring proteins can be obtained. This view is 
extended by introducing a new option to extract a set of proteins with their network 
context, thus allowing a detailed investigation of phosphorylations and interactions of 
specific protein datasets.  
 
 Subnetwork extraction 3.1.4
In order to gain the perspective of the proteins in the network format, the visualization 
plays a crucial role. This would give the required perspective and orientation on the 
proteins that are of interest. In order to visualize the proteins in the network format, an 
additional feature was added to the PlateletWeb resource. Subnetworks can be extracted 
from the knowledgebase for proteins identified in proteomic analysis or in a given sample 
of proteins. This can help to visualize and understand the proteins in their network context 
and further emphasis can be given onto the signaling modules. The combination of 
proteomic and transcriptomic information of the platelet proteins, along with the 
phosphorylation, dephosphorylation and interaction data together with the drug 
information and the site- specific information would give a maximum insight of the 
signaling process within the module. Additionally, the differentiation between kinases, 
substrates, platelet proteins, non-platelet proteins and drugs would help to analyze the 
subnetwork module in a much more systematic way. The resulting network can be easily 
saved onto the computer and visualized in vector graphics or can be further imported and 
investigated using the network analysis software, Cytoscape.  
 
 
Case study: LXR and PECAM1 interactions 
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The PlateletWeb resource can be used to investigate the pathways and all the interactions 
of any platelet proteins of interest. Newly identified antithrombotic targets such as LXR 
(Spyridon, Moraes et al. 2011) or the signaling modulator PECAM1 (Moraes, Barrett et al. 




The central network around the two isoforms of the liver X receptor (LXRα and LXRβ), 
presents all interactions and known phosphorylation events obtained using the subnetwork 
extraction feature of PlateletWeb. The LXRβ isoform has been detected in platelets and it is 
therefore visualized in yellow. Phosphorylated platelet proteins are presented in red. The 
interaction network reveals a kinase-substrate relationship between the LXRα and the 
casein kinase CSNK2A1. Furthermore, the PlateletWeb knowledge base presents options to 
explore the antithrombotic effects around the LXRβ. By first extracting the neighboring 
interactions and then focusing on the GP6 receptor downstream signaling implied to be 
associated with LXR binding effects observed in platelets (Spyridon, Moraes et al. 2011), the 
connection between the two can be thoroughly examined. For instance, LXRβ is directly 
interacting with the ryanodine receptor RXRA in platelets, which is associated with the Src 
kinase. This kinase along with the kinases SYK, LYN and FYN is one of the major activatory 
kinases in human platelet signaling (Varga-Szabo, Pleines et al. 2008). It is also very closely 
associated with the GP6 receptor and the LAT protein. Thus, by using interaction and 
phosphorylation information available in PlateletWeb complex network associations can be 
investigated and visualized. 
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Figure 3 - Interaction and phosphorylation network of LXR 
Visualization of this LXR interaction network is created by integrating information from 
multiple sources. The circles indicate the proteins, while the triangles indicate the kinases. The 
interactions in the network are depicted using the gray lines and the phosphorylations and 
dephosphorylations using the green lines. Phosphorylations are in turn specified according to 
their source of detection: red arrows indicate phosphorylations reported from human cells 
(HPRD), blue arrows are used in the cases where a kinase prediction is assigned to an 
experimentally-validated phosphorylation site. The protein nodes are colored according to the 
source of phosphorylation (red indicating that the protein is phosphorylated in human cells 
and blue indicating that the protein is phosphorylated in platelets. The yellow color specifies a 
non-phosphorylated platelet protein. The phosphorylation site is presented on each directed 
edge, providing further information of the kinase phosphorylating on the site.  
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PECAM1 interactions 
One of the essential mechanisms of integrin outside-in signaling is integrin clustering, 
which then leads to dephosphorylation of Src at Y530 and subsequent autophosphorylation 
at Y419. Pecam-1 acts as a positive regulator in integrin a2bb3 engagement, clustering and 
SHP-2 recruitment and activation (Jackson, Kupcho et al. 1997; Jackson, Ward et al. 1997). If 
SHP2-Pecam1 localization is absent, dephosphorylation of Src doesn’t take place, which 
leads to defective downstream signaling and delay in cell spreading, clot retraction and 
focal adhesions. Phosphorylation of both ITIM-motifs of PECAM1 (Y663, Y686 = Y690, Y 
713) is needed for recruitment and activation of SHP2 (= PTPN11) (Newman and Newman 
2003). Example of the regulation of collagen stimulated platelets through PECAM-1. The 
modification of the interaction of PI3KR1 to LAT and GRB2-associated binding protein 1 
(GAB1) (Moraes, Barrett et al. 2010) can be visualized in a network context additionally 
including SRC to examine phosphorylation events and identify PTPN11 (also known as 
SHP2) as key counter-player for dephosphorylation events. 
 
Figure 4 - Interaction and phosphorylation network of PECAM1 
The interaction network of PECAM1 showing its interactions, phosphorylations along with the 
kinases and the proteins associated with it.  
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However, the subnetwork extraction is not restricted to a single protein. The following 
figure represents the visualization of the vWF signaling subnetwork extracted from the 
PlateletWeb knowledgebase which contains the list of platelet proteins, non-platelet 
proteins, kinases, substrates, interactions, phosphorylations, dephosphorylations, drugs, 
and drug targets. However, only a few drugs were shown in the picture for improved 
visualization and simplicity. 
 
Figure 5 – Extraction of subnetwork from the complete human interactome 
A subnetwork can be extracted from the human interactome including the protein 
information, the phosphorylations, the interactions and the drug targets. 
 SAGE/Proteome Distribution 3.1.5
Considering all the SAGE (Dittrich, Birschmann et al. 2006) and proteomic data for the 
platelet proteins, an enrichment analysis was performed. The main challenge is to find and 
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integrate the vast amount of reliable data which is available from multiple resources. The 
figure below shows the proteins detected on the SAGE and proteome level in biological 
processes of the platelet proteins. The analysis reveals that the term “translation” contains 
the highest percentage of SAGE proteins. This is partly carry-over effect from 
Megakaryocytes, however, there is also translation in platelets, in particular upon activation 
(as shown in the example by the Weyrich group (Weyrich, Schwertz et al. 2009)). An 
extremely pure preparation of platelets (Dittrich, Birschmann et al. 2006; Dittrich, 
Strassberger et al. 2010) was used for library preparation. 
 
Figure 6 - Distribution of platelet proteins according to detection level 
 
 Platelet Enrichment 3.1.6
Biological processes were tested for enrichment in platelets. The top most significantly 
enriched specific terms were plotted against the negative log10 of the P value and colored 
according to their general functional category. Number of platelet proteins and total 
proteins for each term are given in parentheses. There is enrichment of terms related to 
transport, membrane organization, actin-filament based processes, and GTPase-mediated 
signal transduction. 
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Figure 7 - Platelet enrichment: Functional analysis of Biological Process 
 
 
Figure 8 - Platelet enrichment: Functional analysis of Molecular Function 
51 | P a g e  
 
 
Figure 9 - Platelet enrichment: Functional analysis of Cellular Component 
 
Functional characteristics of platelet genes and gene products are stored in the knowledge 
base, including the GO categories. This allows a functional characterization of the platelet 
network. Comparison of the GO functional categories of the platelet interactome with those 
of the entire human interactome network indicated a significant enrichment of platelet 
relevant biologic processes such as “vesicle-mediated transport” (P value = 1.54 × 10-26), 
“small GTPase mediated signal transduction” (P value = 1.08 × 10-15), and “actin 
cytoskeleton organization” (P value = 4.09 × 10-10) (Figure 7). These processes are well 
established in the platelet as they are needed for platelet exocytosis, cytoskeleton 
organization and shape change. Similarly, enriched molecular functions mediate key 
platelet processes such as “actin binding” (P value = 8.51 × 10-12) and “cytoskeletal protein 
binding” (P value = 1.09 × 10-11) (supplemental Figure 8A), while cellular components were 
enriched for mitochondrial compartments and membrane components (supplemental 
Figure 8B).  
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 Platelet-specific kinase tree reveals distribution and enrichment of tyrosine 3.1.7
kinase substrates in human platelets 
Site-specific phosphorylations from public databases were extracted to incorporate the 
central phosphorylation signaling network into the PlateletWeb resource. This was mainly 
based on experimental data of human cells and tissue expressions published in literature 
(Hornbeck, Chabra et al. 2004; Keshava Prasad, Goel et al. 2009). The extracted human 
phosphorylations consist of 10,441 human proteins with 73,734 phosphorylation sites.  
From them, 28,800 of the phosphorylations account for platelet phosphorylation sites, 
which represent around 39% of the total phosphorylation sites. These literature-derived 
data were complemented by a set of 533 phosphosites experimentally measured in human 
platelets (Zahedi, Lewandrowski et al. 2008), of which 16 sites have not yet been described 
in the human proteome. 
Data on both human and platelet phosphorylation sites were further distributed according 
to the residue and this showed a majority of sites (over 50% in both cases) are on a serine 
residue and an almost equal amounts of threonine and tyrosine phosphorylations (around 
22% each, in both cases).  However, in contrast, the experimentally validated platelet 
phosphosites contain a substantially lower share of around 4% tyrosine phosphorylations 
combined with higher percentage (around 80%) serine phosphorylations.  
By supplying information about the responsible kinase, phosphorylation sites can be 
analyzed in the network context. The main theme for this would be the kinase-substrate 
relationship. In this regard, the focus is mainly on the phosphorylated platelet proteins 
associated with a kinase. These represented only 23% (814) of all phosphorylated platelet 
proteins (3,532). On the other hand, 3,080 distinct phosphorylation sites have the 
associated kinase. However, kinase data for experimentally validated phosphorylations was 
available for only 69 phosphosites. A novel network-based algorithm was used to predict 
potential kinases for these sites (Linding, Jensen et al. 2007; Miller, Jensen et al. 2008), which 
resulted in kinase predictions for a further 436 sites yielding a total kinase annotation for 
505 (94.5%) phosphosites. When introduced into the entire platelet phosphoproteome, 
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these predictions contribute to 16% of all modification events with available kinase or 
phosphatase information 
The entire platelet proteome dataset contains 229 kinases (43.5% of 526 total human 
kinases), 162 (70.7%) of which have well described substrates in the platelet proteome. 
Nearly all (216, 94%) have documented phosphorylation sites. The kinase families TK, 
CMGC and AGC contain the highest percentage of platelet kinases. The number of kinases 
belonging to each kinase group is separated into numbers for platelet kinases and non-platelet 
kinases. Then, the percentage of platelet and non-platelet kinases in the respective groups is 
calculated. A total of 218 platelet kinases and 295 non-platelet human kinases are considered. 
Dephosphorylation is achieved by 73 platelet phosphatases (38.2 % of 191 total human 
phosphatases) of which 24 have characterized substrates. 
 
Table 9 - Platelet kinome in relation to all human kinases  




kinases (in %) 
Non-platelet 
kinases (in %) 
AGC 34 29 15.60 9.83 
Atypical 12 26 5.50 8.81 
CAMK 22 52 10.09 17.63 
CK1 5 7 2.29 2.37 
CMGC 35 28 16.06 9.49 
Other 21 57 9.63 19.32 
RGC 0 5 0.00 1.69 
STE 27 20 12.39 6.78 
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kinases (in %) 
Non-platelet 
kinases (in %) 
TK 51 39 23.39 13.22 
TKL 11 32 5.05 10.85 
 
 
All platelet kinases were mapped onto the human kinome tree (Miller, Jensen et al. 2008) in 
order to analyze them and their substrates in a phylogenetic context. 
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Figure 10 – Human Kinome Tree 
Most of the platelet signaling pathways relies on kinases, which allow phosphorylation of 
many proteins in the platelet after stimulation. The assembled platelet interactome consists of 
229 platelet kinases from overall 513 human kinases. Mapping the platelet kinase 1and 
substrate data onto the phylogenetic human kinome tree we marked platelet kinases 
according to their level of platelet expression (proteome, transcriptome or both) and show the 
number of platelet and non-platelet substrates for each kinase as two-coloured bars next to its 
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name. Substrates information is presented as integrated into PlateletWeb from human 
phosphorylation databases. The overall distribution evidences abundance of PKC kinases and 
Src-family which are found in most of the platelet activation signaling pathways. 
Mapping the platelet kinase and substrate data onto the phylogenetic human kinome tree 
the platelet kinases according to their level of platelet expression (proteome, transcriptome 
or both) were marked and showed the number of platelet and non-platelet substrates for 
each kinase (data in the supplement).  The majority of platelet tyrosine kinases were found 
on the proteome level. In order to get the detailed analysis, the tyrosine kinase subtree was 
extracted for detailed analysis from the main phylogenetic tree.  
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Figure 11 - Tyrosine Kinase tree 
The Tyrosine kinase subtree reveals a strong representation of Src-family kinases, which have 
many characterized substrates in platelets and mediate platelet activation through numerous 
phosphorylation events.  
In order to get the detailed overview of the kinase families (Manning, Whyte et al. 2002), an 
enrichment analysis was performed. The tables below show the results of the enrichment 
analysis. 
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Total kinases p-value 
Corrected 
p-value 
TK 51 39 90 0.01 0.08 
Other 21 57 78 0.01 0.08 
CAMK 22 52 74 0.04 0.11 
AGC 34 29 63 0.11 0.13 
CMGC 35 28 63 0.06 0.11 
STE 27 20 47 0.06 0.11 
TKL 11 32 43 0.04 0.11 
Atypical 12 26 38 0.23 0.26 
CK1 5 7 12 1 1 
RGC 0 5 5 0.08 0.11 
All kinases 218 295 513   
 
 
Enrichment of kinases in platelets according to the phosphorylated residue (** Dual-
specificity kinases are not represented, therefore the sum of the column doesn’t equal the 
number shown) 
Table 11 - Enrichment of kinases in platelets according to the phosphorylated residue 
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Total kinases p-value 
Corrected 
p-value 
ST Kinases 136 215 351 0.29 0.29 
Y Kinases 51 45 96 0.06 0.12 
All ST and Y 
Kinases** 
187 260 447   
 
Enrichment of kinase substrates in platelets according to the phosphorylating kinase family 
(* The substrates can be targeted by more than one kinase family, therefore the sum of the 
column doesn’t equal the number of total substrates) 













CMGC 363 463 826 0.67252 0.76 
AGC 308 360 668 0.584902 0.75 
TK 222 167 389 1.52E-05 1.37E-04 
CAMK 89 138 227 0.118601 0.18 
STE 74 52 126 0.002967 0.01 
Other 60 107 167 0.027813 0.05 
Atypical 47 90 137 0.02 0.045 













TKL 35 21 56 0.009605 0.03 
CK1 24 28 52 0.888071 0.89 
All Substrates* 804 989 1793   
CMGC 363 463 826 0.67252 0.76 
 
 
Enrichment of kinase substrates in platelets according to the type of phosphorylating 
kinase - (* the substrates can be targeted by more than one kinase family, therefore the sum 
of the column doesn’t equal the number of total substrates) 
Table 13 - Enrichment of kinase substrates in platelets according to the type of 
phosphorylating kinase 















580 741 1321 0.609655 0.61 
All distinct 
substrates of Y 
Kinases 
222 167 389 1.52E-05 3.04E-05 
All ST and Y 
substrates* 
804 989 1793   
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Although kinases of the tyrosine and AGC family are relatively abundant in human platelets, 
no significant overrepresentation of a particular kinase family could be detected after 
multiple testing correction. Analogously, the enrichment of platelet kinase substrates 
according to kinase family and residue was investigated. The analysis yielded a significant 
enrichment of platelet substrates of STE (P = 0.013), TKL (P = 0.03) and predominantly 
substrates of the TK kinase family (P value = 1.4 × 10-4), also reflected on the residue level 
by a significant enrichment of tyrosine-specific kinase substrates. The STE family contains a 
broad repertoire of kinases important for the upstream signaling in the MAPK/ERK 
pathway (MAPKKK kinases). The TK group contains the main activatory kinases of the Src-
family for which a large number of platelet substrates have been and they participate in 
processes such as collagen and vWF-induced platelet activation (Gardiner, Arthur et al. 
2010).  
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 Protein domains 3.1.8
 
Further analysis indicated that gated interaction mediating domains SH2 (supplemental 
Figure 5) are overrepresented in platelets, consistent with their role as counterparts of 
tyrosine kinases through recognition of tyrosine phosphorylated residues (Liu, Jablonowski 
et al. 2006).  The most often occurring protein domains in platelets are listed. The y-axis 
depicts the –log10 of the P value (Fisher test). The top 10 significantly enriched domains 
include RAB domain, Serine threonine kinase and Tyrosine kinase domain. Furthermore, 
the gated interaction mediating domains SH2 and SH3 are overrepresented due to their 
crucial role in platelet activation. 
 
Figure 13 – Protein domains  
Enrichment of protein domains and their distribution 
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Analyzing the building blocks of the platelet signaling network in terms of domain 
architecture, many of the most frequent domains among hub proteins (platelet proteins 
with more than 50 platelet interactions) are mediators for protein-protein interactions 
including adaptor domains. These include the gated interaction mediating domains SH2, 
SH3 as well as kinase domains which are crucial for signaling and dynamic switches in 
complex formation of the highly connected central phosphorylation network. Domains 
found in platelet proteins with the highest number of interactions (a total of 27 platelet 
proteins with over 50 platelet interactions, some proteins containing more than 1 listed 
domains). The number of proteins containing the respective domain is shown. 
 
Figure 14 – The number of proteins with over 50 interactions contained in the domain 
Number of proteins  





7 SH2 Src homology 2 domains 
7 S_T_kinase Serine_Threonine protein kinases, catalytic domain 
6 SH3 Src homology 3 domains 
5 CC Coiled Coil 
5 Tyr_Kinase Tyrosine kinase domain 
2 ACTIN Actin 
2 C1 
Protein kinase C conserved region 1 (C1) domains 
(Cysteine-rich domains) 
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Number of proteins  





2 C2 Protein kinase C conserved region 2 (CalB) 
2 TM Transmembrane Domain 
1 ARM Armadillo/beta-catenin-like repeats 
1 B41 Band 41 homologues 
1 CASc 
Caspase, interleukin-1 beta converting enzyme 
(ICE) homologues 
1 GS GS motif 
1 LIM Zinc-binding domain present in Lin-11, Isl-1, Mec-3 
1 MH1 MAD homology 1 
1 MH2 MAD homology 2 
1 PH Pleckstrin homology domain 
1 RHO 
Rho (Ras homology) subfamily of Ras-like small 
GTPases 
1 RHOGAP GTPase-activator protein for Rho-like GTPases 
1 SP Signal Peptide 
1 Tyr_Phos Protein tyrosine phosphatase, catalytic domain 
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Number of proteins  





1 UBQ Ubiquitin homologues 
 
The results conclude multiple facts considering PlateletWeb as a base. The comprehensive 
dataset which was assembled contained various sources with high manual curation 
information. Most of the proteins detected exclusively on the proteome level make the 
dataset more reliable. The proteins identified on the transcriptome level, also contributed 
equally to the PlateletWeb repository. The fact that platelets don’t have nucleus means that 
they can’t perform the transcription, however translation is definitely possible if mRNA is 
left from the megakaryocytes from which the platelets are derived. Platelets contain a pool 
of mRNA which can be spliced and translated in a signal-dependent manner (Denis, Tolley et 
al. 2005; Dittrich, Birschmann et al. 2006; Schwertz, Tolley et al. 2006; Rowley, Oler et al. 
2011). Large-scale proteomic data is crucial for understanding the systems biological 
background of cellular processes as well as for identifying potential new biomarkers in 
human diseases as recently shown for atherothrombosis (Tunon, Martin-Ventura et al. 
2010; Dittrich, Birschmann et al. 2011) . 
Interestingly, there are a lot more phosphorylation events than dephosphorylation events 
available from HPRD. This can be explained by the fact that phosphorylation triggers most 
of the activatory and inhibitory pathways in platelets and a tight regulation is needed to 
ensure signaling events take place in an organized and strictly defined manner. Therefore, a 
high number of kinases are needed to fine-tune platelet’s responses.  
The PlateletWeb database is flexible to include and extend any newly available data or 
change in the present information. The extensive usage of the Perl scripts and the MySQL 
database help the easy transformation and inclusion of any additional information into the 
resource. Additionally, the website design is also easily extensible and scalable to cope up 
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with huge amount of information. Both the database and the resource allow the additional 
extensions which might be required when completely new functionality has to be added. 
Apart from the additional features, there is a huge possibility to bridge multiple species 
together. For instance, a protein is found in the human proteome is identified as a platelet 
protein. It is also possible to scale this information on multiple species for example on a 
mouse and see the further information of the same protein in the mouse proteome and get 
the detailed analysis of it. This example shows the capability of this resource when an 
exponential growth of the database with additional information at sight. .  
The platelet interactome statistics revealed few key notes when compared with the 
previous version. The increase in the largest component, (from 70% to 84%) showcases the 
fact that the proteins are connected between themselves leaving very few singletons behind 
(decreased from 26.04% to 14.06%). All the enrichment analysis performed was based on 
the connecting graphs, and this implicates that a reasonable amount of proteins were 
considered for the enrichment analysis that was performed. This higher number of proteins 
participating in the enrichment analysis provides with more concrete results. Furthermore, 
the average degree of the network has a whooping increase from 2.951 to 6.771 illustrates 
the higher connectivity possessing in the network. This was possible because of the 
increased number of interactions included with in the network. 
The identification and assembly of the kinases into the PlateletWeb provided a strong base 
for understanding the platelets in more detail. A phosphorylation network consisting of all 
the kinases and networks was also been assembled for further analysis. A comprehensive 
list of human kinases extracted from Manning et al (Manning, Whyte et al. 2002) and later 
were used for reference and validation of the HPRD phosphorylation data. Thus, the entire 
platelet proteome dataset contained 229 kinases (43.5% of 526 total human kinases), 162 
(70.7%) of which have well described substrates in the platelet proteome. Nearly all (216, 
94%) have documented phosphorylation sites. 
The PlateletWeb knowledge base presents a variety of advanced options for systems 
biological analysis of platelet signaling. Each protein has been provided with characteristic 
features from the functional and network context along with the technique for identification 
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in platelets (level of detection). The phosphorylation status of all proteins can be analyzed, 
distinguishing individually between phosphorylations derived from published literature 
and those directly measured in human platelets. Furthermore, information on physical 
properties such as isoform-specific sequence information, presence of transmembrane 
domains, isoelectric point and molecular weight data are provided and searchable which 
could be helpful tool for the analysis of Western Blot and 2D Gel experiments. Associations 
with diseases can be found using a key-word functionality search in the description of 
proteins. The resource even allows users to combine various search options into a more 
complex advanced search concentrating on specific platelet proteins. 
To better understand the platelet commitment in processes such as immune defense, a 
functionality search (using GO terms) results in proteins involved in “immune response“ 
and associated functions. Additionally, it is possible to combine GO terminology with the 
phosphorylation state, level of detection and presence of particular protein domains to 
retrieve groups of proteins fulfilling the search-defined criteria. Drug information provides 
additional insight about platelet proteins associated with specific drugs. As an example, 
results on pharmacological modification by inhibiting prostacyclin receptors retrieve 
analogues of prostacyclin (Epoprostenol, Iloprost, and Treprostinil). The knowledge base 
thus allows a comprehensive and detailed analysis of the platelet not only on a single 
protein level but also on the scale of network regulation and functional association of 
signaling components. A detailed tutorial on the usage of the platform is presented in 
Supplementary Material.  
The intriguing feature of PlateletWeb, the subnetwork extraction helps to understand the 
proteins from multiple aspects. For instance, a similar protein can be found performing 
special functions in multiple networks. The flow of the information in each of the networks 
could be easily identified using this feature of PlateletWeb. Additionally, the example of LXR 
provides an insight of how the mechanism can be understood and used. 
Motivating the insights on the platelet tyrosine, the conclusion indicates that most of these 
kinases were found on the proteome level. The detailed analysis of the phylogenetic tree 
further provided the substantial motivation to this fact. The kinase subtree revealed a very 
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strong representation of Src-family kinases, which have many characterized substrates in 
platelets and mediate platelet activation through numerous phosphorylation events. In 
contrast to this, a clear absence of kinase groups such as the neurotropic tyrosine kinases 
(TRKA, B, C) and neural growth kinases (ROR1) can be observed, as these are kinases with a 
high specificity for neuronal tissues. 
The analysis on the protein domains, especially on the enrichment test suggested that the 
most often occurring domain is the RAB domain. RAB proteins have a specific function in 
membrane tethering and fusion by recruiting factors, which interact with SNARE proteins 
and form SNARE complexes (Zhang, Naslavsky et al. 2012). The enrichment of these 
domains might be explained by their strong involvement in vesicle transport, which is also 
the underlying mechanism of endocytosis. Additionally, platelets were also found enriched 
for the endocytosis pathway and the two findings correspond well with each other 
(Boyanova, Nilla et al. 2012).  
The SH2 and SH3 domain enrichment is well explained by the fact, that these domains bind 
to tyrosine phosphorylated residues of platelet proteins after platelet activation 
transmitted by the kinase Src (Liu, Jablonowski et al. 2006). 
In another aspect of the analysis on the protein domains, the high interacting proteins with 
over 50 interactors were considered. Interestingly the placement of the domains was 
changed, SH2 replaces RAB as the most often occurring domain among highly connected 
proteins. This change can be explained due to the fact that this domain is an important 
signal transductor during platelet activation and many proteins after tyrosine 
phosphorylation can bind to these domains. Therefore, it can be assumed that the 
enrichment of such domains ensures a more global signal transduction. The analyses 
underline the tight functional relationship of SH2-domain proteins and tyrosine kinases 
(Liu, Jablonowski et al. 2006) in platelets, which is well reflected by the overrepresentation 
of tyrosine kinase substrates and SH2 domains in the enrichment analyses. 
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3.2 Motif analysis 
 Analysis 3.2.1
To get more insight into the way how information is processed in the anucleate cell type, 
network motifs which proteins participate in certain complexes of interactions were 
considered. In order to eliminate the bias of already known biological knowledge when 
extracting subnetworks, the network motifs were introduced. Although having the 
knowledge is useful, an unbiased method to search for structural topological elements in 
the configuration of the network can provide with advanced insights on the complete 
network. Network motifs can be defined as the unique patterns of interactions between 
proteins that appear significantly more often in the real network compared with 
randomized networks. These patterns are considered to be selected by evolution. 
Therefore, motif analysis introduces new insights on the types of network regulation. In the 
transcription networks, they were shown to have important information processing 
functions (Milo, Shen-Orr et al. 2002; Shen-Orr, Milo et al. 2002; Alon 2003; Mangan and Alon 
2003). This implies that the found motifs might be of importance for the regulation of the 
observed system. Here, the integrated platelet network consisting of protein-protein 
interactions (undirected edges) and kinase-substrate interactions (directed edges; arrows 
from the kinase to the substrate) focusing on a set of 14 motifs were analyzed, which are 
previously been described to have an impact on information processing in transcriptional 
networks (Milo, Shen-Orr et al. 2002) as well as in signal transduction networks (Zaidel-Bar, 
Itzkovitz et al. 2007). 
There are multiple tools available to detect the network motifs – Pajek (Batagelj and Mrvar 
1998; Batagelj and Mrvar 2003; De Nooy, Mrvar et al. 2005) MAVisto (Schreiber and 
Schwobbermeyer 2005; Schwobbermeyer and Wunschiers 2012), FANMOD (Wernicke and 
Rasche 2006), MFinder software (Kashtan, Itzkovitz et al. 2004) to name a few. Alongside, 
there are multiple plugins available for Cytoscape – Netmatch (Ferro, Giugno et al. 2007), 
CyClus3D (Audenaert, Van Parys et al. 2011) are frequently used. 
Here, the MFinder software (Kashtan, Itzkovitz et al. 2004) was used in order to detect 
network motifs in the platelet proteome. The software enumerates all n-node patters and 
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classifies them into one of several topologically distinct sub-graphs. The original network is 
randomized 1000 times keeping the incoming and outgoing edges at each node the same for 
all the randomized networks. This rewiring of the edges would create complete random 
networks with random connections for all the 100 randomized networks. Subgraphs that 
are observed significantly more frequently in the real network than in randomized 
networks are regarded as network motifs. In the table below, the higher the z-score, the 
higher the significance of the particular motif in the real network. Scores are shown for all 
14 motifs from Zaidel-Bar et al (Zaidel-Bar, Itzkovitz et al. 2007). The motif ID indicates the 
corresponding number of the same motif defined Milo et al (Milo, Shen-Orr et al. 2002).   
 
Table 14 – Motif analysis – the significant motifs and their Z-scores 
Motif number Motif ID N-Real N-Rand stats N-Real Z-Score 
1 110 831 261.9+-18.3 31.16 
2 108 128 86.6+-10.9 3.79 
3 102 46 15.3+-4.2 7.31 
4 238 3432 806.9+-35.6 73.72 
5 350 1699 406.9+-130.9 9.87 
6 5086 2611 352.0+-60.5 37.32 
7 478 128 30.7+-17.5 5.57 
8 6558 106 12.9+-4.2 21.95 
9 908 50 26.3+-8.5 2.77 
10 6604 56 28.6+-10.3 2.65 
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Motif number Motif ID N-Real N-Rand stats N-Real Z-Score 
11 5022 116 17.5+-6.7 14.68 
12 5084 829 165.8+-31.4 21.12 
13 4574 420 97.3+-22.8 14.13 
14 13262 2038 155.0+-34.1 55.16 
 
 
Figure 15 – Motif analysis  
The 8 key motifs showcased in a simple module of network  
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The 8 key motifs with high biological importance and highest z-values are shown in the 
figure. There are altogether 686 platelet proteins, which build up these motifs. All kinases 
and proteins shown on figure 2 participate in the most significant eight motifs. The two 
motifs which occur most often in the platelet network are motif 110 and motif 238, which 
contains only interactions. The eight motifs allow various kinases to be partners of different 
logical circuits and allow each kinase to play different roles in different regulation types. 
Interestingly, results included two top motifs critical for rapid information processing: One 
is a scaffold motif which captures one enzyme or kinase by a scaffold protein which then 
furthermore allows the kinase to choose between two substrates. In Motif 13(4574 in the 
above depiction) for example one protein (the protein YWHAG from the 14-3-3 family) 
scaffolds an enzyme and two alternative substrates, in this particular case the kinase are 
PKC, which alternatively phosphorylates SRC or GSK3A. The main protein could serve as an 
adaptor molecule for the phosphorylation event, thereby facilitating the kinase activity in 
the one or other direction. A systematic examination was conducted to see how often a 
certain protein in the motif appears among all found motifs of this type, and came to a 
conclusion that in the position of the scaffold protein mainly kinases and actual scaffold 
proteins were most frequently appearing.  
For motif 13(4574 motif) not only the kinases such as FYN and SRC were found but also the 
adaptor proteins such as GRB2, YWHAG and phosphatases (PTPN11, PTPN1) in the first 
position in the motif, which plays the role of a scaffold for the enzyme and its substrates. 
The second position was exclusively taken by kinases, among which SRC, AKT1, INSR and 
PKC were overrepresented. The third and fourth position was predominantly occupied by 
the following proteins: CTNNB1 (Catenin), GRB2, CAV1, STAT3. These are the most frequent 
substrates of kinases from this particular regulatory motif. The same motif, consisting of 
these as well as other proteins, is found 19 times in the integrin signaling pathway, which 
indicates the high importance of such a pattern in the interactome. 
Motif 110 assembles signaling complexes. For instance, the analysis on ILK PINCH pathway, 
crucial for integrin signaling(Lange, Wickström et al. 2009) (Supplementary Information, 
fig.S4): the ILK kinase, which phosphorylates GSK3also known as GSK3) is found 
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together with Paxillin – an adaptor protein needed for ILK localization to focal adhesions 
and downstream integrin signaling(Nikolopoulos and Turner 2001). 
 
Figure 16 - Motif analysis on the ILK network: 
In the above figure (A), all the proteins interacting with ILK (Integrin-linked Kinase), were 
extracted and visualized according to their interactions and phosphorylation state (red line, 
phosphorylation; grey line, interaction; blue line, kinase-substrate prediction). The proteins 
were colored as follows – red, protein phosphorylated in human cells; blue, protein 
phosphorylated in platelets; yellow, a platelet protein. The kinases are represented by 
triangles. The motif 110 was found once in the above network (B), containing the integrin-
linked kinase (ILK), its substrate GSK3B and the adaptor molecule Paxillin (PXN), which 
regulates ILK localization to focal adhesions. 
Another biologically motif of high relevance is the motif 8 (6558), where an adaptor protein 
acts as a scaffold for two kinases and their common substrate. Systematical analysis of the 
proteins contained in the motif, showed that on position 1 there was an actual adaptor 
protein in most cases and positions 2 and 3 were taken by kinases. A relevant biological 
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example is the binding of DOK2 to HCK and SRC kinases, which both phosphorylate RASA1. 
Thus, it can be concluded that this motif might be important in regulating platelet cellular 
processes. 
The proteins that were found in most motif structures were taken into consideration and 
then constructed an interaction and phosphorylation network using these proteins. They 
build a dense interaction network, and some of the most prominent platelet kinases can be 
found, such as PKC and LYN. 
Motif analysis has further increased our knowledge of what possible mechanisms might be 
involved in the platelet phosphoproteome and interactome network, pinpointing motif 110 
as the pattern with highest significance. Therefore, it can be suggested that motif 110 plays 
a leading role in cellular signaling of the anucleate platelet. The bingo analysis was 
performed on all the motifs and the network motif results for 110, 4574 and 6558 are 
shown in the supplementary material. 
To perform the motif analysis a complete interactome network has to be created. This 
means that if the network is changed by adding or removing the amount of information in 
it, there is a possibility of the network information to be changed. However, this does not 
mean the information the motif analysis is providing is falsified. It can be understood as, 
with the amount of information content we have at hand, the results offer the first hand 
insight of the network patterns. When further information content is added or deleted with 
respect to the interactome network, it is then possible to make a comparative analysis and 
focus on what patterns have actually changed and the implication of the information. Also 
the comparison analysis on the other species networks on the similar proteins would also 
yield yet more useful information which might not be easily understood. Additionally, the 
statistical analysis that is performed decreases any false positives that might be already 
creeping in to the network. The motif analysis can be thus considered a highly reliable way 
to identify the network patterns that might be existing in the interactome networks. 
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3.3 Identifying functional modules using semantic similarity and Heinz 
(Qualitative analysis) 
 Qualitative analysis 3.3.1
The extraction of functional modules is a key in understanding the proteins in the context of 
their interactions. Lots of research was conducted on this fact, however each of the methods 
that were described have both their advantages and disadvantages. The key for this 
research is to minimize the disadvantages and bring out the functional modules which 
provide with most concrete information.  
The main problem is that the large proteomic datasets (with over 100 proteins) yield huge 
networks, which are difficult to interpret and must be considered to further divide them 
into smaller networks for understanding it. However, in many cases, this results in losing of 
the important information. Additionally, the proteins are rarely grouped according to their 
functional relevance. In most of the cases, the proteins bearing similar functionality tend to 
interact together more tightly rather than the other way round. When the subnetwork is 
built, the proteins with higher functional relevance are expected to come together and 
provide the functional module with higher information content in it.  
Additional to this, in the proteomic analysis, it’s not always necessary to get the differential 
expression numbers. In other words, a number defining the proteins role in the network is 
missed. So, all the proteins should be equally rated to get the interacting network out of all 
the proteins. However, this does not satisfy the needs of the end users. The difficulty in 
quantifying the proteins which are identified in the proteomic analysis and extracting the 
most biologically informative subnetwork prompted to further investigate and improvise 
the concept of extracting the subnetworks from the proteomic analysis. 
The main objective of the qualitative analyses is to derive the biologically interesting 
subnetworks of interpretable size or of fixed size from large scale protein protein 
interaction data by logically quantifying the proteins and their interactions. This problem 
was previously addressed in multiple ways (Ideker, Thorsson et al. 2001; Dittrich, Klau et al. 
2008). For the first time, Idekar et al has analyzed and expressed this as the problem of 
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finding optimal-scoring subgraph. This problem was then transformed by dittrich et. al, to 
the well-known PCST problem from Operations Research. With this an alternative NP-
completeness proof they could solve large instances of this problem in reasonable 
computation time. This solution which is retrieved can be considered as the optimal 
solutions. The algorithm takes another step, and it calculates the suboptimal solutions with 
given Hamming distances to previously found solution. However this algorithm is given on 
the basis of the proteins which have the differential expression data associated with it. In 
our scenario, we do not have the required differential expression data, but just the proteins 
which are identified in the sample proteins.   
In order to address this issue of handing of the proteins, a scoring on the interactions 
(edges) was made. An edge score can then be used to focus on the most relevant module. 
The edge score, in this case, should reflect some kind of functional relevance with in the 
protein-protein interactions (PPI). GO similarity has been developed as measurement of 
similarity of two proteins in terms of their functional annotation. The main reason behind 
using the semantic similarity is due to the fact that the proteins with a high functional 
similarity will be involved in similar cellular processes, thus the interaction between then 
can be assumed to be more relevant. 
Here the Gene Ontology semantic similarity was used as a basis for functional scoring of the 
PPI. Various measurements of GO similarity have been described in literature, here a score 
based on the similarity measure proposed by Schlicker was developed.  
 
 The Beta Uniform Mixture Model 3.3.2
The Beta Uniform Mixture model (BUM) was introduced by Pounds and Morris et al 
(Pounds and Morris 2003) in 2003.  
This approach can be used in microarray or proteomics data where a statistical test is 
calculated for each gene/protein in the dataset resulting in a single p-value. This p-value is 
interpretable when using only one statistical test, but in the case of multiple testing the p-
values lose their meaning as Type I error rates.  
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The principle of the BUM is that under a null hypothesis where none of the genes/proteins 
is of any importance, the p-values will be uniformly distributed. In the case where there are 
genes with a specific importance to the experiment (holding a signal), there would be an 
overrepresentation of small p-values and the histogram will represent a peak near the zero. 
This alternative hypothesis can be modeled by a beta distribution where the p-values are 
visualized as a mixture distribution of signal and noise component. 
 
 Example: why edge scores 3.3.3
A small example here illustrates the importance of using the semantic similarity of the 
genes and scoring it onto the edges. In this example, let A and B are two proteins which are 
of interest and are identified in the sample proteins. Both A and B are connected over three 
different proteins, C, D and E. Considering the edges has no scores on them, the solutions 
are either ACB, ADB or AEB. However, when adding the biological insights into this small 
network by using the semantic similarity between the proteins and giving the edges a score 
depending upon the calculated similarity, the maximum scoring graph will always be the 
one with the higher connectivity. In our example, the solution would be only ACB as protein 
C being semantically similar with both proteins A and B.  
 
Figure 17 – The schematic showing the difference in the network when the edge scores are 
included 
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 Calculation of Edge scores 3.3.4
The edge scores of the network are calculated in multiple steps. The complete scenario is 
presented below in the form of steps, for easier readability.  
Step 1: The interactome (original) is randomized twice (random1 and random2) as the key 
idea is to consider the probability of the observed score showing up in the randomized 
distribution 
Step 2: The semantic similarity is calculated using GOSim on all three interactomes 
(original, random1 and random2) by setting the ontology to biological process 
Step 3: The empirical cumulative distribution function (ecdf) is computed, which when used 
as function with an object, returns the percentiles. Here, the object is the Semantic 
similarity scores calculated for the interactome.  
Using the statistical software R, the p-values can be achieved by the following: 
BiologicalProcessFunctionRandom1 <- ecdf(BiologicalProcessRandom1GOScore) 
BiologicalProcessFunctionRandom2 <- ecdf(BiologicalProcessRandom2GOScore) 
where “BiologicalProcessFunctionRandom1” and “BiologicalProcessFunctionRandom2” are 
the functions that are created for the randomized interactomes which contains the GOSim 
scores of the Randomized networks.   
These functions can now provide the percentiles:  
bp_r1percentiles <- BiologicalProcessFunctionRandom1(BiologicalProcessOriginalGOScore) 
bp_r2percentiles <- BiologicalProcessFunctionRandom2(BiologicalProcessOriginalGOScore) 
bp_r1s1 <- BiologicalProcessFunctionRandom1(BiologicalProcessRandom2GOScore) 
bp_r2s2 <- BiologicalProcessFunctionRandom2(BiologicalProcessRandom2GOScore) 
The first two percentiles, “bp_r1percentiles” and “bp_r2percentiles” are calculated for 
attaining the edge scores. The next two, “bp_r1s1” and “bp_r2s2” are calculated in order to 
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test if the randomized interactome GOSim scores are bringing any additional effect to the 
original network. These percentiles are transformed into p-values. 
bp_pvals_r1p <- 1- bp_r1percentiles 
bp_pvals_r2p <- 1- bp_r2percentiles 
bp_pvals_r1s1 <- 1-bp_r1s1 
bp_pvals_r2s2 <- 1-bp_r2s2 
Step 4: These calculated p-values can be fit to the Beta Uniform Distribution (BUM) model 
 
Figure 18 – Beta uniform mixture models and the pi-upper values between the randomized 
and original networks 
 
The left most figure gives a pi-upper of 0.7 is the model for bp_pvals_r1p, the middle one for 
bp_pvals_r2p and the extreme right is for bp_pvals_r1s1. The p-values on the extreme right 
only show the noise and no signal component and the pi-upper is 1. 
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Step 5: Repeat the steps 2, 3 and 4 by setting the ontologies to Molecular Function and 
Cellular Component.  
Step 6: Aggregate the p-values using first order statistic 
Step 7: Fit BUM model to the aggregated p-values to decompose the signal from the noise.  
Step 8: Convert the p-values to heinz scores by setting the FDR using the BioNet package.   
 
 Example: Conversion of percentiles into p-values 3.3.5
The conversion of percentiles into the p-values requires a little more insight, and this can be 
explained with a small example.  
Initially, using the ecdf function, a cumulative distribution function is computed. In order to 
calculate the probability of Original interaction GOSim score greater than, say 2.7, it can be 
mapped onto the curve. Using this value of GOSim as the function parameter, the percentile 
is calculated.  The idea is to see the probability of our observed score of 2.7 showing up on 
the randomized distribution “P[GOSimscore > 2.7]”. It is important to know that the total 
value of cumulative distribution is always 1. Thus the probability is easily attained by 
removing the percentile of data from the distribution.  
 
 
0.5 1.0 1.5 2.0 2.5 3.0 GOScores 
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Figure 19 – Figure depicting the way the percentiles are converted into the p-values 
 
 Node scores  3.3.6
The algorithm requires the node scores to calculate the maximum scoring subnetwork. The 
algorithm was previously considered for the data from the microarray experiment or the 
survival data (Dittrich, Klau et al. 2008). In this module,  the algorithm is extended in order 
to identify the functional modules without any known information except the proteins list 
identified in the proteomic analysis. This implicates a non-availability of the values to 
consider on the node scores. In order to overcome this issue, a node score algorithm is 
constructed. The following figure depicts how the node scores are calculated using the 
already known edge scores which is calculated using the semantic similarity.  
 
Figure 20 – Calculation of Maximum scoring subnetwork 
The proteins identified in the sample are given an adjusted value based on the edge score  
 Nodescore = -avg(connected edge scores) 
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This node scores would help to quantify and provide the most optimal values to the 
proteins identified in the sample. The rest of the nodes in the interactome are given the 
average of all the edge scores to maintain the background distribution of the network. This 
would ensure a constant values of edge scores for all the edges and change in the node 
scores for different samples of data.  
 
 Extracting sub networks 3.3.7
The large-scale proteomic datasets generated in recent years have posed a big challenge for 
developing new strategies to analyze the data in a biologically meaningful way. The large 
number of proteins identified in samples (>100 proteins identified) make it impossible to 
isolate functional modules of sizes suitable for analysis. Just by mapping the proteins onto a 
predefined PPI network is not enough to focus onto the relevantly changed modules 
contained in the sample. Additional functional information on the interacting proteins is 
therefore needed. GO similarity has been developed as a measurement of similarity of two 
proteins in terms of their functional annotation (Guzzi, Mina et al. 2011). The rationale 
behind this scoring system is that proteins with a high functional similarity will be involved 
in similar cellular processes, thus the interaction between them can be assumed as more 
biologically relevant. Therefore, one possible solution to this problem is the addition of 
functional association information onto the edges in the human interactome thereby 
assigning interaction values according to the functional similarity of the gene ontology 
associations of the interacting proteins. Thus, the edge score would reflect functional 
relevance of the particular edge in the PPI.  
A score based on the similarity measure proposed by Schlicker (Schlicker, Domingues et al. 
2006) was developed as detailed in the Experimental Procedures. A functional interaction 
score was developed based on GO semantic similarity values for all three ontologies (BP, 
MF and CC). Proteins from a biological sample were assigned values derived from the 
functional interaction scores, whereas linking proteins from the interactome were given the 
average of all interaction scores. Both protein and interaction scores were added to the 
human PPI network, which contains 55,196 edges and 10,688 nodes. An algorithm for 
84 | P a g e  
 
detection of functional modules was used for extraction of functionally connected 
subnetworks, containing the proteins in the sample. The algorithm searches for maximum-
scoring subnetworks based on the pre-given edge and node scores. Linking proteins from 
the human interactome are included in the solution if this increases the maximum score of 
the extracted subnetwork. These linking proteins might be important players in the overall 
signaling changes of the analyzed protein sample. Using GO semantic similarity for the 
functional interaction scores of interacting protein pairs ensures that the algorithm 
includes paths having high similarity over those having low similarity. Therefore, 
functionally related clusters of proteins are extracted in the final solution along with linking 
proteins with a similar function. As proteomic analyses are often fractionated and detection 
of some proteins proves to be extremely difficult, this approach is useful for unraveling the 
network context of identified proteins along with proteins missing in the original sample 
due to technical difficulties. Scores can be adjusted to a threshold, so that more proteins 
from the original sample are included. Thus, the solution can become more or less stringent, 
including a higher or a lower number of proteins. 
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Figure 21 – A schematic of the idea for identifying functional modules using edge and node 
scores  
 Beta-mixture model (BUM) of Biological Process transformed scores 3.3.8
To combine GO semantic similarity of edges with the topology of the human interactome 
network a new score monotonously dependent on the original Schlicker scores was 
introduced. This score allows a natural way of integrating multiple sources of information 
and is therefore very flexible. A combination of p-values representing different data can be 
smoothly integrated into the framework. The scores are also adjusted to the functionality of 
the human interactome. For the calculation, Schlicker BP score was calculated for the 
human interactome edges and a randomized network of the same size but a different 
topology (same number of nodes and edges, but rewired). The original network scores and 
the scores from the randomized one were used for obtaining empirical p-values. A beta 
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mixture model (BUM) was then applied to determine the information content and the 
signal/noise ratio. The distribution of p-values in this model consists of noise (a uniform 
distribution (under the blue threshold =Pi-upper)) and signal (beta distribution).  
The obtained p-values could be fitted to a beta uniform mixture model (BUM) (Figure 2A) 
indicating that the human interactome contains interacting proteins with high functional 
similarity significantly more often than the randomized network model. The Pi-upper value 
(the threshold separating signal from noise) was 0.46710439372661.  
In the case of the randomized network, the obtained p-values were uniformly distributed 
(Figure 2B), which indicates the lack of any relevant functional dependency for nodes from 
this network. The Pi-upper value in this case was 1. The quality of model fit in both cases 
was assessed by QQ Plots (Supplementary Figure S3).  
Scores were further obtained from GO semantic similarity values of MF and CC based on the 
Schlicker algorithm. Then, a new score was proposed, which smoothly integrates all derived 
p-values from the three ontologies into a single combined score, further used in all our 
analyses (see “Experimental Procedures, Calculation of Functional Interaction Scores”). 
When comparing the information content of each individual score, presented as the 1 - Pi-
upper value of each BUM model, BP showed the highest signal content, followed closely by 
the combined functional interaction score based on all three ontology scores 
(Supplementary Figure S4). 
Differences between the three separate ontologies could be analyzed after running the 
heinz algorithm based on the edge scores only without the node scores and limiting the 
resulting network to a size of 200 in each case to ensure a reasonable comparison. Thus, 
there was no need for changing the False Discovery Rate (FDR) parameter as the algorithm 
searches for the maximum scoring subnetwork limited to 200 nodes.  Results indicated a 
very low overlap between the three ontologies. While BP and CC had 63 proteins in 
common (%), MF was very distinct from both with only 10 and 13 proteins overlap. This 
might be due to the nature of the terms in Molecular Function, which focus more on the 
chemical properties of proteins and isn’t necessarily associated with the same biological 
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process or compartment in the cell. Thus, MF represents a different aspect and contains 
other information not necessarily covered by BP and CC. The distinct nature of all three 
ontologies made it reasonable to combine them in a more suitable score, which would 
contain information from all three ontologies. Therefore, aggregating the pvalues, a score 
which could be used as a combined ready score for the network was obtained. Results show 
that this score is mainly based on BP as the functions of the two resulting networks are very 
similar. This might be because BP has the highest information content and therefore 
influences the final score to a large extent. 
Multiple analyses were performed taking different cases into consideration. The heinz 
algorithm was run considering the size parameter of 200 and giving the nodes a score of 0. 
The edge scores are given the originally derived scores for each of the ontologies without 
the change in the FDR. This revealed that the overlap between the modules derived 
between BP, MF and CC were very low in the edge heinz. There were only 4 proteins which 
were common to all the three ontology runs, which when checked were belonging to the 
proteasome complex. When checked individually between the ontologies, a higher overlap 
was found between BP and CC (63 proteins). Also, MF represents a different aspect and 
contains further more information which need not have to be necessarily covered in the 
other two ontologies. When the aggregated p-value of order 1 was taken, it was close to the 
BP, which can be interpreted as the algorithm is considering the most information from BP 
and combining it with the CC and MF, as BP is with a very high information content.   
In order to validate the algorithm when induced with semantic similarity, vigorous testing 
and analysis was performed. This also proved the point that this algorithm can be used in 
the network of any size. The following case studies provide the results when the algorithm 
is used with different sizes of the network. 
  
 Case study 1: Embryonic stem cells for different ontologies 3.3.9
In order to understand how the algorithm reacts when showcased with the same network 
on three different similarities (BP, MF, CC), the analysis on the study from Brill et al (Brill, 
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Xiong et al. 2009) on embryonic stem cells and their phosphorylations was conducted.  
Using the identified proteins as the nodes of interest, the node scores derived from the pre-
calculated edge scores were included. The size of the resulting network was once again 
restricted to 200 nodes. The aim was to see how well the go similarity scores concentrate 
the network onto biologically relevant information. There was only a very small overlap 
between results with biological data (ESC data, Figure 22) and results with no biological 
information (only edge scores, Figure 23) indicating that there is no bias of the edge scores 
to the network. Furthermore, using the sample proteins gives more specific information 
than taking only edge scores, as it is focusing the network onto a set of nodes which are of 
particular interest and their function. The overlap between the separate ontologies was a 
lot higher in each of the cases pinpointing that node information combined with edge data 
gives a more detailed and consistent biological results than using only the go similarity 
scores. The ESC resulting module shows functional clusters, characteristic for embryonic 
stem cells, such as translation initiation factors, nuclear transport, cell cycle/division and 
MAP-kinase-kinase-kinases (MAPKKK). These clusters are clearly different from the 
clusters obtained by using only edge scores without any node information (Figure 23). In 
this solution there are only complexes with a very high functional similarity. 
 
A set of 200 proteins were taken and the algorithm was implemented with multiple criteria. 
The following table shows a matrix of different criteria and the overlap of the proteins in 
each of the cases. Only the edge information of the proteins was taken and the algorithm 
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Function 
25 16 10 200 13 
Cellular 
Component 
78 70 63 13 200 
 
The table showcases that the aggregated order 1 is similar to Biological process than the 
other two (molecular function and cellular component). Also, the molecular function 
contains the most distinct information with very low overlap among all the three 
ontologies. The solutions for each of the ontologies are also very different reflecting the 
variability between information coming from the three ontologies.  
 
The similar analysis was performed with same edge scores, however this time with the 
nodes in the back ground.  The algorithm was made run on multiple criteria again, and this 
time the results conclude in a different way.  
 
























26 200 51 - 52 
Biological 
Process 
88 51 200 - - 
Molecular 
Function 
- - - - - 
Cellular 
Component 
30 52 - - 200 
 
The number of proteins was once again, 200 and this was once again compared in the 
matrix format. In this scenario, the number of proteins in the solution modules was too 
little in most of the cases. Also in the cases like molecular function, the algorithm could not 
give any module out and the algorithm continues to run to find out the functional modules. 
The algorithm was made stopped in the middle for the molecular function as it is clear that 
there are no or none of the functional modules existing within the set of proteins on the 
molecular functional level. Additionally, the relation between Aggregate interactome 1 and 
3 provides a drastic change.  The following figures show the gained results from the 
algorithm runs.  




Figure 22 - A network solution of ESC proteins with edge scores  
This network depicts the solution achieved from the ESC proteins with the edge scores. The 
functional interaction scores are equal to the aggregated p-values. The size of proteins is 
200 and the subnet edge score was -192.542332563.  
The red shades represent low to high scores from light red to dark red. Edge scores are also 


















Figure 23 - A network solution using only edge scores  
The figure shows the network solution only using the edge scores. Again, the functional 
interaction scores are equal to the aggregate p-values. In this scenario only the edge scores 
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 Case study 2: Extraction of network modules using qualitative proteome data 3.3.10
The main advantage of heinz algorithm is that it can be easily possible to visualize the 
proteins identified in the proteomic analysis even though they are not directly interacting 
(connected) with each other. The heinz algorithm together with the functional similarity 
between the proteins helps to connect these proteins in more optimal way, keeping the 
functional integrity of the analysis intact. In order to validate this, the function was applied 
on two smaller networks (Yang, Xiao et al. 2006), (Liu, Song et al. 2008).  
In the first case, a human gastric epithelial cell line (AGC) was analyzed after infection with 
avian influenza virus (H9N2) using mass spectrometry identifying 22 proteins. These 
proteins were used as the set of interest and analyzed with and without edge scores. In the 
case without edge scores, there was no score applied to the edges and the nodes that are 
identified in the analysis were given a constant value of +5 to assure that they all appear in 
the final network solution. The remaining nodes in the interactome were given a value of -1 
(a negative value, indicating that the proteins might or might not be actively participating in 
the network). The resulting network contains more basic information driven only by the 
nodes from the sample and not integrating any additional biological data. In the alternative 
case, the aggregated pvalues were used to combine the three ontologies and used as the 
edge scores, and the nodes of interest are then derived from the edge scores. Additionally, a 
constant of 10 was added to these node scores to ensure that all proteins are in the 
resulting network. The result with edge scores provided more defined pathway connecting 
keratins to the rest of the proteins (over RAF1). 
Proteins obtained with proteomics analysis can be visualized in a network context, even 
though they are not directly connected with each other. Introducing functional interaction 
scores to the module detection algorithm helps to connect these proteins in an optimal way 
based on the functional context of the protein modules and the scores of the interactions 
connecting them.  
In order to test this, we applied the algorithm on a small biological sample from a human 
gastric cell line (AGC, originating from a gastric epithelial cell line) analyzed after infection 
with avian influenza virus (H9N2) using mass spectrometry. The study identified 22 
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proteins (Wu, Noh et al. 1996). Two separate analyses of this protein sample were 
performed to investigate the advantages of functional interactions scores: including and not 
including interaction scores in the module extracting algorithm (see “Experimental 
Procedures”). When adding functional interaction scores, we used the previously described 
method for combining the three GO similarity scores and proteins from the sample assigned 
a node score derived from the edge score (Figure1B). High constraints for the node scores 
were used to ensure that all identified proteins are found in the resulting network (see 
“Experimental Procedures, Constraints of the algorithm solution”).  
The method with functional interaction scores (Figure 3B) yielded 39 proteins, whereas the 
method without interaction scores extracted 37 proteins (Figure 3A). Both networks 
contain linking proteins and paths, which partially overlap (14 paths and 5 linking proteins 
are same). There are 28 proteins in common for the two solutions but there are also unique 
proteins, which appear only when functional scores are introduced to the edges (AKT1, 
EPB41, GNG4, HRAS, HSPA4, JAK2, KRT5, PDK1, RAF1, YWHAB). The number of literature 
citations for each interaction is very low in the network without functional scores. In the 
network with scores there are five interactions with more than one citation, indicating the 
algorithm chooses well-annotated interactions. 
 
 Case Study 3: Human Blood cell constituents 3.3.11
To test whether our method is applicable for differentiation of various cell types in terms of 
functional modules, we used a proteomics study by Haudek et al (Haudek, Slany et al. 2009), 
where mass spectrometry of human blood cell constituents was performed.   
The module detection algorithm was performed on the protein samples of all 7 cell 
constituents separately: plasma, T-cells, neutrophils, monocytes, platelets, erythrocytes and 
PBMC (peripheral blood mononuclear cell). In the next step, the resulting networks from all 
blood cell types were analyzed for enrichment of biological processes. GO terms containing 
less than 3 or more than 600 proteins were excluded from the analysis. The significance 
threshold of terms in this case was set to a corrected p-value of least 1 × 10-5 in at least one 
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of the cell constituents. Clustering of GO terms was performed with hierarchical clustering 
based on Euclidean distance calculation.  
Blood constituents clustered in a way consistent with their developmental stages. As 
expected, plasma proteins build an out-group, distant from all other blood constituents as 
they are not a cell type. Two big groups are formed (platelets, neutrophils and erythrocytes 
vs. monocytes, tcells and PBMC), which are consistent with hematopoiesis stages. 
There are terms specific to platelets like the term “platelet activation” and hemostatic 
processes, while other terms such as “cell killing” and “leukocyte-mediated cytotoxicity” are 
enriched in monocytes, which biologically differentiate these from other blood cell types. 
Ubiquitin and proteasome processes are highly enriched in three cell types: T-cells, 
monocytes and PBMC (which are a mixture of cells with a round nucleus, including T-cells 
and monocytes). The term “translation” is overrepresented in T-cells and PBMC when 
compared to all other constituents. The biological process “generation of precursor 
metabolites and energy” is overrepresented in monocytes.  
In a second analysis we included significantly enriched terms in exclusively one cell type 
with a p-value of at least 0.05. Specific functions for each cell type could be extracted, 
indicating the resulting modules are cell-type specific and focus on the characteristic 
functional modules of the given cell type (Supplementary Table S1). 
 




Figure 24 – Human blood cells constitutents; the protein network identified using the sample 
of proteins  
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Figure 25 – Heat map of the human blood cell constituents; Testing of the module detection 
method for various cell types  
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 Analysis on the concept of functional modules 3.3.12
The concept of extraction of the proteins of interest, and trying to get to see the 
functionality they possess is a vast study and loads of new ideas break open to investigate 
this issue. The interconnected proteins may or may not follow a pattern which makes the 
analysis difficult to interpret in first place. It’s highly impossible to formulate and interpret 
the extraction and visualization of the proteins as the needs of the end users differs at 
different points of the experimental analysis. However, this limitation does not stop from 
investigating new ideas on extracting the functional modules using statistical and 
mathematical functions, which might be repeatedly used for any scenario. 
An extreme research is being done in trying to extract the functional modules however 
every method that come across has both the advantages and disadvantages in using it. In 
this research the proteins were scored as a function of the interaction score. The main 
power of having this formulation is that it provides the ease of using this on any protein 
sample as it is pre calculated. Additionally, the nodes with high scoring interactions are 
downgraded so that they are not dominating the overall possible solution. As an example, 
the proteins with higher number of interactions might come up more often than expected in 
any protein sample taken. This might bias the results of the functional module. 
Downgrading these hubs according to the network structure can provide the actual result 
which might be on higher biological relevance. 
After analyzing the performance of the method on small networks, our next step included 
large-scale proteomic studies of blood constituents. The overexpression of the term 
“translation” in T-cells might be explained with the fact, that there is a high protein 
turnover and proliferative events in these cells causing an increased protein production. 
Another interesting aspect was the enrichment of proteasome and ubiquitin processes in 
particularly three cell types: T-cells, monocytes and PBMC. The existence and role of the 
proteasome in immune as well as non- immune cells has been extensively reviewed by 
Ebstein et al (Ebstein, Kloetzel et al. 2012). Interestingly, these three cell types constitutively 
express three proteasome subunits (PSMB8, PSM10 and PSMB9), which are normally not 
included in the proteasome but induced after stimulation. Thus, they build the so called 
immunoprotesome, which plays an important role in antigen presentation by MHC class I 
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molecules, cell proliferation, cell signaling and cytokine production (Ebstein, Kloetzel et al. 
2012). This type of proteasome has been identified mainly in dendritic cells and antigen 
presenting B-cells. As monocytes replenish the pool of macrophages and dendritic cells in 
the body, the immunoproteasome is found in these cells as well. T-cells show a constitutive 
expression of all three molecules and the immunoproteasome facilitates protein 
homeostasis and cell proliferation in these cells (Zaiss, de Graaf et al. 2008). PBMCs are a 
mixture of macrophages, monocytes and lymphocytes therefore it is logical that they would 
also have this function. All three proteins are present only in the described three cell types, 
and are lacking or not fully expressed in the other blood cells. This might explain why there 
is an overrepresentation of proteasome processes when compared to the profile of other 
blood constituents.  
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3.4 Phosphoproteomics (Quantitative analysis) 
 Workflow 3.4.1
The understanding of the proteins and their functional involvement in the network requires 
in depth research and thus provokes to invent new methods. Additionally, the kinase 
substrate relationships in the network context provide with a vast knowledge on the 
signaling networks in the context of the phosphoproteomics and its analysis. The heinz 
algorithm discussed in the previous chapters would help in determining the underlying 
network signaling, however, this does not necessarily provide the biologically significant 
information. The quantitative analysis performed in mass spectrometry provides the new 
information about the proteins and the differentially expressed quantified value.  
This quantitative information gained from the analysis can be used as the node scores for 
the heinz algorithm. Additionally, site specific information is induced and added into the 
node scores provide with highly significant information as the resulting modules. In order 
to test this concept and idea, a network which has all the phosphorylation sites from the 
dataset that are associated with kinases were taken into consideration(Rigbolt, Prokhorova 
et al. 2011). Additionally, the kinase information is added from the PlateletWeb database in 
order to provide the real kinase substrate relationships and see the real signal flow. This 
would then become the additional information provided to the data set, which is not either 
detected or specified in the proteomic analysis performed on the proteins.  
The methodology of quantitative analysis of the dataset using heinz consists of various 
steps, which are detailed in the steps below. 
The analysis was performed on the research resource (Rigbolt, Prokhorova et al. 2011), and 
the genes were then mapped to the PlateletWeb dataset. This was important because the 
dataset contained the mappings of the IPI, however, the PlateletWeb was using the Gene 
identifiers in order to identify the gene uniquely. The dataset defines profiling of the 
proteins in two different conditions (treatments), NCM and PMA. For this analysis, the NCM 
was used as it contains the information and was well defined in the dataset. The dataset 
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provided with 4 different values at 4 different time points defined for NCM which was taken 
into consideration.  
Furthermore the dataset defines class1 sites, which were also used to filter the dataset as it 
provides with most concrete dataset for the analysis. This dataset once mapped with the 
gene identifiers can be ready for the step 2 of the analysis.  
All the mapped proteins which are under NCM time line and have the class1 sites can now 
be made ready to convert into heinz scores to get the functional modules out. For this an 
additional 1 is added to the complete dataset so that the logs and sumlog of the data can be 
calculated. This marks as an important step for this method as the sumlog of the differential 
dataset of 0 is not defined. In other words, if there is no change recorded in the dataset, the 
log value of this number tunes to undefined value, which is not an intended scenario. In 
overcome this fact, an additional value of 1 is added to the complete dataset, which would 
mark the same factor without a huge difference in the logarithmic values. Later, just to 
figure out the regulation, the absolute log value for all the 4 time lines are taken. This would 
mean that there are no negative values for the down regulation of the data. 
The site information has to be added to the proteins that are identified in the dataset. At 
first the discrimination between the sites having a mapped kinase from the interactome, 
and the sites not having a known kinase has to be made. The emphasis is given to the sites 
with associated kinases. This will help to have only the sites with the kinases in the network 
(this will be the edge file for heinz). Additionally, it’s important to note that there are not 
edge scores given, so the edge score is considered to be 0. The largest connected component 
of the network in Cytoscape which is containing the interactome kinases and the dataset 
kinases and proteins is used as the edge file for heinz.  
Each of the proteins might have multiple sites, and here only the maximum scoring sites 
was considered when more than 1 site is given for a protein. To achieve this, the sumlog is 
calculated for all the 4 values and the maximum sumlog between two sites was taken into 
consideration. This can be also termed as “Sumlog of the rows (4 timelines) and then the 
maximum of the sumlog columns (sites)”. 
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An FDR for each of the 4 absolute logs was provided individually so that when the 
subnetwork is extracted by the algorithm, the number of positive nodes is at least 50 in 
each case. This file can be termed as the input node file for the heinz algorithm. 
Finally, with both the node file and edge file (even though its 0 in this case) intact, the heinz 
algorithm can be executed in order to find the maximum connecting subnetwork on all the 
4 different time lines. With the resulting information, the scores for all the 4 different points 
are then extracted and combine the resulting protein networks into one single network. 
This can be visualized using the Cytoscape in all the 5 different time points.  
This methodology when performed resulted in the information content, which is described 
below.  
From the dataset, 67 phosphorylated proteins were resulted of which 14 are kinases and 
120 phosphorylation sites with kinase information was also obtained. Additionally from the 
human interactome (PlateletWeb), 33 kinases were added building up 159 phosphorylation 
events. This numbers might not be a huge exploration on the first sight, however, when all 
the 4 time lines are visualized; this revealed many patterns in the networks which can be 
further investigated.  
An output figure for the 24 hours timeline is shown below (Figure 23). The colors represent 
the absolute logarithmic values (log2) of the phosphorylation ratio between the 
measurements at 24h when compared to the control. The interval of values is depicted in a 
color scale from blue (low value) to red (high value). Nodes represent the maximally 
changing phosphorylation site. Kinases from the human phosphoproteome extracted from 
literature information (PlateletWeb knowledge base) are shown as yellow triangles. The 
network allows detailed investigation of the signal flow during embryonic stem cell 
differentiation with special focus on single phosphorylation sites and clusters of 
phosphorylation sites changing in a similar manner such as the phosphorylation targets of 
CDK2. Thus, integrated network analysis of the phosphoproteome helps to identify changes 
not only on a single protein level, but also indicators for network dynamics which could be 
shown in the example given in Figure 24.  




Figure 26 – The module at 24 hours of time line  
 
To further analyze the results, we focused on a classical pathway playing a crucial role in 
growth and cell division of hESCs. The Raf/MEK/ERK (RAF1/MAP2K1/MAPK1) pathway is 
visualized with the changes of phosphorylation at each time point. This signaling module is 
only completed after adding the MAP-kinase-kinase (MAP2K1) and its phosphorylation by 
RAF1 (Wu, Noh et al. 1996), both derived from the human phosphoproteome. Moreover, 
regulatory switches are revealed by following changes in signaling of a specific module of 
CDK2 phosphorylating SNW1 at S224 (Wu, Noh et al. 1996) (max 1h) and ORC1 at S273 
(Mendez, Zou-Yang et al. 2002) (max 6h). SNW1 is a coactivator that enhances transcription 
from some Polymerase II promoters (Zhang, Dowd et al. 2003), while ORC1 initiates DNA 
replication (Hemerly, Prasanth et al. 2009). A recent study revealed that phosphorylation of 
ORC2 Protein Dissociates Origin Recognition Complex from Chromatin and Replication 
Origins (Lee, Bang et al. 2012). This phosphorylation was mainly on threonine sides, but 
they were regulated by the CDK2 kinase, thus, the phosphorylation here may also play a 
role in dissociating ORC1 from chromatin. 





Figure 27 -  Four time points of quantitative phosphoproteomics analysis of the 
RAF/MEK/ERK pathway 
 
The methodology is first of its kind and takes understandably long time. This can, however 
be fine-tuned to the needs and can also be optimized with respect to the resulting data. 
Various added values can be achieved using this method. One of the most prominent usages 
would be to have a detailed analysis of regulation of phosphorylation sites which is 
understandably lacked in the original dataset. This dataset can be very well visualized in the 
context of protein-protein interactions. Apart from the site specific information between 
the proteins, the additional interactions and their associations can be easily identified in the 
context of the networks. Secondly, the temporal changes in particular sites (time point 
changes) can be easily identified and investigated further. Furthermore, the 
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phosphorylation events are added so that the regulation in the dataset can be analyzed; for 
example the kinases and the proteins are available but the link between this may be missing 
in the dataset. Another key factor which makes this an active methodology is because of the 
capability to visualize and track the signaling flow inside the pathway. This from a different 
perspective, the motif analysis is simplified. Additionally, it provides the power to identify 
individual modules, extract them and further analyze depending upon the context. Apart 
from all these important usages, it is also possible to identify the clusters of phosphosites 
which are up or down regulated in a similar pattern.  
With all the above discussed usages, the method can be termed as a value added service 
that can be brought along with the heinz algorithm and PlateletWeb dataset.  
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4 Discussion 
Systems biology focuses mainly on the complex interactions with in the biological systems, 
which is not possible without proper informatics associated with it. Informatics can be 
considered as a service, which can be easily induced into any science to help it carry on the 
research quicker and simpler. In general, the clinic directors hire the doctor students for the 
tasks associated with the biology. However, the systems biological tasks require an inner 
depth of knowledge on multiple informatics aspects which requires the informaticians to 
get in. A cleverly established database which can be easily expandable and scalable with the 
new information, easily accessible with it providing the right information, proper curation 
from multiple sources, high modulation, assembling the data together with no 
redundancies, proper management, data validation, sophisticated data analysis, its 
integration and finally the visualization if requires etc. would all be possible with a proper 
background in the informatics along with the knowledge on the biological requirements. 
Additionally, the extreme challenges like the algorithms for the proteomic analysis 
demands for contemporary ways of inducing multiple sources of knowledge and high 
capability of analyzing the data structure. These algorithms normally would requires to 
define once and they should be capable on working in any kind of implementations which 
they are intended to work on. 
 
4.1 PlateletWeb 
The PlateletWeb knowledge base is a medium which helps investigate the signaling 
mechanisms and modular functions in a comprehensive manner. This functionality 
however is not just limited to just the hemostasis. The usability scale ranges from the 
pattern which can be as simple as retrieving the information about the protein of interest to 
the scale where the sample of proteins which are obtained in the proteomic analysis. The 
proteins can be visualized in the sub network format based on the interactome constructed 
in the PlateletWeb resource. With this the complete multi-tasking and functional 
modularity of the platelets can be analyzed and studied. In order to make sure the quality of 
the PlateletWeb resource applicable for the newest findings, I have performed the analysis 
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on the newly identified antithrombotic targets such as LXR (Spyridon, Moraes et al. 2011) 
and on the signaling modulator PECAM1 (Moraes, Barrett et al. 2010). It is concluded that 
with the help of this resource, these targets can be easily investigated in the context of 
interacting partners and phosphorylation events. Additionally, a complete platelet and 
kinase enrichment is performed and this helped me to analyze the kinases in depth. A 
detailed analysis was also performed in order to see that the PlateletWeb provides a 
semantic, systematic and a structured overview of the platelet interactome and 
phosphoproteome including validated interactions and phosphorylations based on 
published studies and experimentally validated phosphorylation sites in platelets. 
Additionally, the inclusion of drugs and drug targets enabled the systemic analysis of 
pharmacological regulation in platelets. The complete website with the relational database 
as the basis enabled me to create new specific features for the PlateletWeb website which 
would ease the data retrieved from the PlateletWeb resource. Advanced search options in 
the PlateletWeb website for drugs, diseases and functional annotations effectively enable 
the implementation of data mining strategies for the detection of novel platelet specific 
targets. Additional bindings and cross links created for each and every protein helped to 
reduce the false positives in the resource. All proteins are also associated with their drug 
associations, allowing bidirectional navigation through the network of drug target 
relationships. This similar format was also ensured in the kinase substrate relationships. 
Protein kinases are key regulators of platelet signaling. The kinase activity, which is crucial 
in a variety of human diseases such as cancer is associated with over 400 human diseases 
(Melnikova and Golden 2004). The knowledge about human kinases and their substrates in a 
network context, coupled with information on associated drugs can indicate putative new 
pharmacological targets. My analysis provided the first insights on to the enrichment 
methodologies to check how and which platelet proteins play the key role. Modern 
phosphoproteomic studies deliver large amounts of valuable data on site-specific 
phosphorylation including quantitative measurements of dynamic signaling events (Rigbolt, 
Prokhorova et al. 2011). Usually, however, they offer no information about the 
corresponding kinase which thus remains the missing link in the reconstruction of the 
cellular signaling cascades from phosphoproteome data. Here, the bioinformatical 
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predictions and literate-curated networks may provide the necessary kinase associations 
and deliver a cellular context for the analysis of the raw experimental data. This integrated 
analysis, however, is not restricted to a single protein level. The proteins of interest from a 
sample can be investigated at an instance by extracting a subnetwork from the human 
phosphoproteome, kinome and interactome and PlateletWeb allows the visual 
representation of resulting subnetworks in vector graphics or export for further analysis in 
Cytoscape. Various pathways considered to play a key role were extracted, visualized and 
analyzed for signal regulation. Alternatively, platelet proteins belonging to characteristic 
pathways (defined by KEGG) are highlighted and available for pathway network analysis.  
The enrichment analysis of drug targets and disease genes in hub platelet proteins were 
also performed and this resulted in the first insight which proclaimed that the highly 
connected proteins in the network are among the enriched drug targets and disease genes. 
The large amount of available platelet data gave rise to a series of analysis aimed at 
elucidating the systems biological background of platelet signaling. Using pathway data 
from KEGG the investigation is based on the enrichment for a specific pathway in platelet 
proteins. After testing whether the found platelet proteins are significantly higher in 
number than expected by chance, the test concluded that a group of pathways are found 
with significantly higher number of platelet proteins. Among the top-enriched pathways are 
key pathways in platelet signaling: cytoskeleton reorganization and focal adhesion. The 
PlateletWeb knowledge base is a comprehensive internet-based resource for platelet 
researchers, which presents intriguing novel options for a systems biological investigation 
of platelet signaling. It provides many opportunities for the investigation of dynamic 
network restructuring also in regard to the recently recognized condition-dependent 
further tasks of the platelet in infection, inflammation, cancer and sepsis (Leslie 2010). 
Future efforts in the development of PlateletWeb will focus on the integration of novel 
platelet studies (e.g. new transcriptome information from recent RNA sequencing data 
(Rowley, Oler et al. 2011)) and updated datasets from the source databases while 
maintaining the high standard of data curation.  
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4.2 Other databases (mouse and cd molecules) 
 CD Molecule database 4.2.1
Cluster of differentiation (CD) molecules are cell surface molecules and targets for 
immunophenotyping (Fabryova and Simon 2009). These CD molecules can act in several 
ways, for instace as receptors or ligands (Gregory 2000). Using the PlateletWeb database, a 
more specific database was created, termed the CD molecule database (CDDB). This is an 
interaction database for CD molecules, similar to the PlateletWeb database. It also provides 
the information about the proteins, protein information and summary, the KEGG pathways, 
the architeture types and tissue expression. This database gives the first insight to provide 
information as how the PlateletWeb database can be extended into further more specific 
modules. The database front end, created with PHP shows a list of total interacting proteins 
and a list of interacting CD molecules only. This small scale database can be used to gain 
information when conducting the experiments with cluster of differentiation molecules. 
However, similar to the PlateletWeb database, this database contains the information only 
on the human proteins. This might be a problem for preparing experiments as mos of them 
are conducted not on human beings but on the studied model organisms such as mus 
musculus.  
Thus, this CD molecule database was expanded to the species mouse by including the 
orthologs and interlogs from the human proteome. The complete search functionality was 
also added to this database to retrieve the relavant data from the database. This database 
was designed by me and was helping the practical training student, Benjamin Merget for his 
thesis. 
 
 Mouse database 4.2.2
Mice have become a major animal model in platelet research and more and more data for 
this organism becomes available, the establishment of cellular signalling network of murine 
platelets becomes an interesting and realistic perspective. A first insight was perfomed and 
the data is curated manually from multiple databases (Kanapin, Batalov et al. 2003; 
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Vassilatis, Hohmann et al. 2003; Senis, Tomlinson et al. 2007; Li, Cai et al. 2010; Turner, Razick 
et al. 2010; Flicek, Amode et al. 2011; Rowley, Oler et al. 2011). The first database was 
constructed using the mouse proteome and interactome information topped up with the 
information on each protein and its functional information. This was then matched with the 
proteins from the PlateletWeb to contain the interlogs and homologs. The construction of 
the database, however requires lots of criteria to be considered and can be understood as a 
first step for the potentially high end research. 
   
4.3 Semantic similarity 
Semantic similarity measures are useful to assess the physiological relevance of protein-
protein interactions. Using the annotations like Gene Ontology (GO) it is possible to quantify 
the similarity between the genes based on their functions. Proteins that interact in the cell 
are likely to be performing similar functions or involved in similar biological processes or 
even found on the same component. Here an algorithm was introduced to extract the 
functional modules from the proteins identified in the proteomic analysis using the 
semantic similarity and the exact approach (heinz). The GOSim package (Frohlich, Speer et 
al. 2007) was used in order to calculate the semantic similarity between the proteins. The 
GOSim package offers an easy way to gain insights to the functional modules of the genes.  
 
 Semantic Similarity of Terms 4.3.1
The semantic similarity between the terms has to be considered before moving onto the 
similarity between the genes. Various methods (Resnik 1995; Lord, Stevens et al. 2003; 
Schlicker, Domingues et al. 2006; Wang, Du et al. 2007; Schlicker and Albrecht 2008; 
Benabderrahmane, Smail-Tabbone et al. 2010; Yu, Li et al. 2010) are available to calculate the 
semantic similarity between two terms. The usage of the semantic similarity was discussed 
thoroughly in multiple reviews (Guo, Liu et al. 2006; Xu, Du et al. 2008; Pesquita, Faria et al. 
2009), and Resnik was considered the best applicable measure for GO based semantic 
similarity on PPI. 
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Semantic similarity measures can be broadly classified into two groups, the edge based and 
the node based. The similarity based on the shared paths between two terms is given by the 
edge based (Cheng, Cline et al. 2004; Wu, Su et al. 2005; Yu, Gao et al. 2005; del Pozo, Pazos et 
al. 2008) methods. The node based methods (Resnik 1995; Jiang and Conrath 1997; Lin 
1998) on the other hand rely on comparing the properties of the input terms taking their 
terms themselves, ancestors and the descendants into account. Information content (IC) is 
the concept which is commonly used in all these approaches. The IC gives a measure of how 
specific and informative the term is. The probability assigned to a term is defined as its 
relative frequency of occurrence. The root has probability p(root) = 1 if it is unique. The IC 
of a term c can be quantified as the negative log likelihood,  
          
where p(c) is the probability of occurrence of c in a specific corpus being normally 
estimated by its frequency of annotation. This is also called as most informative common 
ancestor (MICA). 
IC provides a measure of a terms specificity that is independent of its depth in the Ontology. 
This is due to the fact that the IC of a term is dependent on its children but not on its 
parents. Because of this main reason, the approaches based on IC are less sensitive to the 
issues of variable semantic distance and variable node density. However, IC is biased 
because terms related to areas of scientific interest are expected to be well annotated when 
compared to other terms. Even in such cases, the use of the IC still makes sense from a 
probabilistic point of view, as it is more probable and less meaningful that two gene 




Resnik (Resnik 1995) uses the concept of information content “IC” to define more consistent 
semantic similarity measure. The similarity between two terms is high if the information 
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shared between them is higher. This shared information is considered by the set of common 
ancestors in the graph. The amount of shared information and thus the similarity between 
the two terms is quantified by the information content of the common ancestors. Thus, the 
semantic similarity between two terms can be given as  
   Resnik  1  2      
          
           
where s(c1, c2) is the set of common ancestors of terms c1 and c2.  
The above equation can also be written as: 
   Resnik  1  2      
          
          
In this measure, the minimum similarity is zero and there is no maximum for this measure.  
 
“Lin’s” and “Jiang and Conrath’s” Measure 
Resnik measure is effective in determining the information shared by two terms; however it 
does not consider how distant the terms are from their common ancestors. Lin (Lin 1998) 
then defines the similarity between two terms as the ratio of the distance of terms and the 
information needed to fully describe the two terms. The commonality of the terms can be 
defined by the common ancestors of the terms.  To take that distance into account, both 
Lin’s and Jiang and Conrath’s (Jiang and Conrath 1997) measure relate the IC of the MICA to 
the IC of the terms being compared. The information needed to fully describe both terms is 
the sum of their information, since the random selection of one term is independent of the 
random selection of the second term. The defining equation is given by 
SimLin(c1, c2) = 
             
             
 
SimJC(c1, c2) = 1 – IC(c1) + IC(c2) – 2 x IC(cMICA) 
In both the cases, S(c1, c2) are the sets of common ancestors of terms c1 and c2. The 
minimum possible similarity value in these methods is 0 and the maximum is 1. 
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However, being relative measures, similarity measures of both Lin and JC are displaced 
from the graph. The measures are proportional to the IC differences between the terms and 
their common ancestor, independently of the absolute IC of the ancestor. The relevance is 
not considered in both the measures.  
 
Schlicker Measure 
To overcome this limitation, Schlicker (Schlicker, Domingues et al. 2006) tuned up with a 
measure which would combine both Lin and Resnik similarity measures. This would help to 
take the relevance information into account, which takes the lowest common ancestor into 
account. The probability of the lowest common ancestor reflects the level of detail. Generic 
terms do not have a high relevance for the comparison of the exact function of different 
gene products.  The Schlicker measure is as follows: 
   Rel  1  2      
          
(
          
                 
        ) 
This equation can as well be written as: 
SimRel(c1,c2) = SimLin(c1,c2) x (1-p(cMICA)) 
Similar to Lin, Rel measure also has the minimum similarity value of 0 and the maximum 
similarity value of 1. The relevance of a term decreases with the increasing probability in 
this method. 
 
 Semantic Similarity between Genes 4.3.2
Genes are usually annotated with more than one gene ontology terms in the GO database. In 
this scenario, in order to calculate the semantic similarity between the two genes, the 
semantic similarity between all the GO terms of each gene should be compared. 
Computation of maximum and average similarity between any pair of GO terms is defined in 
the existing tools like FuSSiMeg (Couto, Silva et al. 2003), eGOn (GÜnther, Langaas et al. 
2006) and DAVID (Huang da, Sherman et al. 2009; Huang da, Sherman et al. 2009). However, 
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eGOn and DAVID approaches measure gene functional similarities based on the probability 
of the appearance of GO terms or the kappa statistics of similar annotation terms correlated 
with different genes and ignore the semantic relations (is-a and part-of) among these terms 
in the GO graph.   
Functional Semantic Similarity Measures between Gene-Products (FuSSiMeG) is a 
functional similarity measure between gene-products that compares the semantic 
similarity between the terms in their annotations. This is a hybrid semantic similarity 
measure, which integrates the information content with conceptual distance (edge based) 
factors. In order to compute the similarity between functional properties, FuSSiMeG 
assumes that two gene-products have a functional similarity when they are annotated with 
similar functional terms. FuSSiMeG then measures the similarity between gene products by 
the maximum similarity between their assigned terms.  
Given two terms g and g´ annotated with GO terms t1, t2 … tn and t1´, t2´… tm´ the functional 
similarity between two genes g and g´ is defined as  
 
Here the semantic similarity measure ranges between 0 and 1.  
Another semantic similarity measure, G-SESAME (Wang, Du et al. 2007) addresses the 
critical need of determining the functional similarities based on gene annotation 
information from heterogeneous data sources. This algorithm focuses on the relationships 
of the GO terms with in a specific ontology to determine the semantic similarity which helps 
in gaining the consistent measurement between two GO terms.  
Another graph based method is GOSemSim (Yu, Li et al. 2010), which is an R package for 
measuring the semantic similarity among GO terms and gene products. Many functions are 
provided by the GOSemSim package, geneSim is specifically used to compute the semantic 
similarity between GO descriptions of gene products. Different measures can be used along 
with this function, some of them being “Wang”, "Resnik", "Lin", "Rel", and "Jiang".  However 
Sim gene(g,g´) =  max   sim(ti,tj´) 
    i=1,…,n 
    j=1,…,m 
115 | P a g e  
 
when this package is tested on the human species for the complete interactome with 
multiple measures, the output has extremely biased results near the minimum and the 
maximum. When two similar genes are compared, it would give a 1 as the output value. 
Many gene products are forming complexes which perform the same biological function 
and therefore have almost similar functionality. However, in order to identify the 
differences in similar genes (not the same gene); the focus has to be shifted to similar 
method providing higher resolution.  
In this regard, a complementary tool which beholds similar functionality is GOSim (Frohlich, 
Speer et al. 2007). Taken FuSSiMeg as basic idea, GOSim extends the resulting value by 
further normalizing to account for an unequal number of GO terms for both genes. 
 
The GOSim package systematically integrates existing tools like FuSSiMeg by integrating its 
functionality and providing additional similarity concepts for gene products. This is 
implemented as a package for statistical computing environment R and has been integrated 
into the CRAN project.  
 
 Unique score between two genes  4.3.3
The usage of GOSim package helped to gain the semantic similarity between two genes 
using the function getGeneSim. However, the Gene Ontology is defined in three broad 
categories – Biological Process (BP), Molecular Function (MF) and Cellular Component (CC). 
The Semantic similarity has to be calculated for given two genes on all the three ontologies 
considering one at a time. This would result in three scores for the given two genes. For 
instance, when quantifying the semantic similarity between the genes “VASP” (Entrez gene 
identifier – 7408) and “SRC” (Entrez gene identifier – 6714) the GOSim package returns the 
semantic similarity for BP as 0.4608678, CC as 0.3648075 and MF as 0.2174619. Schlicker 
et al (Schlicker, Domingues et al. 2006) introduced funsim score from the scores of BP and 
𝑠𝑖𝑚𝑔𝑒𝑛𝑒(g,g´) 
Sim gene(g,g´) =         ------------------------------------------------- 
                                          𝑠𝑖𝑚𝑔𝑒𝑛𝑒 𝑔 𝑔 𝑠𝑖𝑚𝑔𝑒𝑛𝑒 𝑔´𝑔´  
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MF of a pair of gene products. Two gene products with a high score in one ontology but an 
average score in the other can be considered average matches. However, in such case, their 
score should be higher than the score of two gene products that are average matches in 
both categories. Here, simply adding the two scores or taking the average scores would not 
distinguish between these two cases. In order to gain the distinction, the squaring of the 
scores favors high similarity in one and a low score in the other one over average scores in 
both ontologies. The funSim score ranges between 0 for completely unrelated gene products 
and 1 for gene products with identical functionality. Due to its definition, the funSim score is 
lower than the average two scores in most cases. In order to obtain a more intuitive score, 
the rfunSim score (Schlicker, Rahnenfuhrer et al. 2007) was defined for two gene products 
were defined. However, although the three ontologies scores were considered, I stick to the 
funSimAll, with all the three scores considered together, once again defined by Schlicker et 
al [http://funsimmat.bioinf.mpi-inf.mpg.de/help3.php]. 
The funSimAll score is calculated from the Scores of BP, MF and CC for a pair of genes. It is 
defined as: 




            




            




            




In this equation, max(BPscore), max(MFscore) and max(CCscore) denotes the maximum 
possible score for BP, MF and CC respectively. Once again, the funSimAll score ranges 
between 0 for completely unrelated gene products and 1 for gene products with identical 
functionality.  Introducing the semantic similarity calculated between two genes VASP and 
SRC, the result would be  



















The funSimAll result of this equation is 0.130924. However the proteins are highly 
annotated in the Biological Process as the interacting proteins share the common biological 
goal and they are comparatively less in both Molecular Function and Cellular Component. 
This would directly affect the funSimAll calculation, if the annotations are missing for one or 
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more of the ontologies for the set of proteins. Prominent genes might lose functional 
information if they are not annotated in all 3 ontologies. In order to overcome this issue, the 
GOScores are converted into the p-values and these are then aggregated using the aggregate 
statistic based on the distribution of the order statistics (Dittrich, Klau et al. 2008; Beisser, 
Klau et al. 2010). Thus a single functional edge score is achieved for each of the gene pairs.  
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5 Conclusion and Outlook 
The systems biology insights are possible due to the cleaver construction of the database. 
The PlateletWeb is a systems biological workbench, is a valuable resource which provides a 
much needed complete information for the analysis of platelet signaling in the functional 
context of integrated networks. The establishment of this database provides trivial and vital 
information about the platelet proteome and the interactome when analyzing the protein 
alone or when considering its role in the network context. The information gained from 
multiple resources and databases, improves the accuracy and the consistency in the data 
and decreases the false positives if any. In general, meeting the highly relevant and 
computational challenges of systems biology regards for powerful biological database 
which was then developed to knowledgebase. The functionality of the website with its 
advanced features like the “advanced search” provides the information only specific to the 
context. Additional information about the protein physical attributes, the Gene ontology 
information about each of the protein, the drug target information and the disease 
associations provide an ample function tools for platelet signaling analysis. The graphical 
visualizations available in the PlateletWeb knowledgebase helps understand the protein 
from the context of the network modules. The kinase, phosphatase information provides 
the signaling flow in the network context and provides ample of information for complete 
analysis of the modules. PlateletWeb allows detailed topological, interactome and 
phosphoproteome analysis and thus serves as a valuable platform for the comprehensive 
cellular network analysis, for instance regarding PGI2 and ADP P2Y12 receptor signaling 
pathways.  
The analysis on the interactome network provides new insights on how the data is 
distributed across the network. Also, the platelet specific kinase tree revealed the 
distribution and enrichment of Tyrosine kinase substrates in the human platelets. The motif 
analysis gives the insights on how the information is processed in the anucleate cell types. 
The unique patterns of interactions between proteins that appear significantly more often 
in the real network compared with randomized networks were identified, thus gaining the 
new insights on the types of network regulation. The 8 key motifs with high biological 
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importance and highest z-values are identified. The complete detailed analysis was 
performed to understand these key motifs and the way the motif 4574 play a key role in the 
network regulation. Motif analysis has further increased the knowledge of what possible 
mechanisms might be involved in the platelet phosphoproteome and interactome network 
and identifying the most important motifs in the platelet interactome. The availability of 
Gene Ontology information for most of the proteins helped in understanding the proteins in 
terms of their biological process, molecular functionality and the cellular component. This 
information is used for the complete gene enrichment analysis which provides the insights 
for how the proteins are scattered and grouped together. Taking this Gene ontology 
information about each of the proteins, the quantification of the relation between two 
proteins was achieved. This was then introduced to the heinz algorithm resulting in the 
biologically significant modules for the first time. This quantification, performed by taking 
the gene ontology information between two proteins which are interacting between each 
other and then checking for the semantic similarity between them. This helped to extract 
and understand the modules from the complete network of proteins which are specific to a 
certain criteria. A complete testing was performed by taking already existing modules and 
also by investigating new modules in different proteins identified in multiple samples.  
The database can be further extended and this was also performed by extracting only the 
CD molecules and identifying the components. Using the PlateletWeb database, a more 
specific database was created, termed the CD molecule database (CDDB). This database has 
the capability to expand to multiple species and this was clearly concluded on a high note 
with the introduction of mouse interactome data. The orthologs and the interlogs of the 
mouse and human data can bring the complete analysis of the protein with focusing on 
multiple aspects. The resource can be paired up with multiple species, which for obvious 
reasons can be a valuable asset to the field of science and medicine.   
  
120 | P a g e  
 
6 Supplementary material 
Supplementary Table 1 - Information on Gene Ontology enrichment analysis for Motifs 
110 (5a), 4574 (5b) and 6558 (5c). Biological process (BP), molecular function (MF) and 
cellular component (CC) analysis are presented with the corrected p-value and the number 
of proteins from the real network (=biological network), which are associated with this GO-
term. The p-values are adjusted using the Benjamini and Hochberg correction(Benjamini 
and Yekutieli 2001). 
Abbreviations: RN - Number of proteins from real network; NPGT - Number of proteins 
from GO-term; 
Supplementary Table 1a – Biological Process; Motif 110: 
Total number of proteins in the network: 300; Number of all GO annotated Proteins: 8652 
GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
8286 4.53E-12 3.49E-10 12 24 Insulin receptor signaling pathway 
7169 3.16E-11 2.24E-09 27 172 
transmembrane receptor protein 
tyrosine kinase signaling pathway 
43066 5.94E-10 3.64E-08 27 195 negative regulation of apoptosis 
43069 7.50E-10 4.44E-08 27 197 
negative regulation of programmed cell 
death 
1775 2.33E-08 1.12E-06 21 145 cell activation 
30036 6.08E-08 2.77E-06 21 153 
actin cytoskeleton organization and 
biogenesis 
30029 6.92E-08 3.07E-06 22 168 actin filament-based process 
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GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
45321 1.07E-07 4.64E-06 18 118 leukocyte activation 
7265 2.86E-07 1.16E-05 15 88 Ras protein signal transduction 
51049 8.48E-07 3.14E-05 18 135 regulation of transport 
32879 9.48E-07 3.43E-05 18 136 regulation of localization 
 
  
Supplementary Table 1b – Molecular Function; Motif 110: 
Total number of proteins in the network: 308; Number of all GO annotated Proteins: 9108 
GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
4715 3.07E-16 2.65E-14 17 36 
non-membrane spanning protein 
tyrosine kinase activity 
4713 4.80E-15 2.48E-13 30 156 protein tyrosine kinase activity 
19904 3.08E-11 9.35E-10 23 127 protein domain specific binding 
4697 8.18E-09 2.11E-07 8 15 protein kinase C activity 
5057 9.04E-09 2.23E-07 20 128 receptor signaling protein activity 
4716 3.24E-08 7.61E-07 7 12 
receptor signaling protein tyrosine 
kinase activity 
32403 2.22E-06 4.25E-05 14 92 protein complex binding 
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GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
5158 5.20E-06 9.60E-05 7 22 insulin receptor binding 
43560 6.24E-06 1.11E-04 4 5 insulin receptor substrate binding 
19992 1.08E-05 1.74E-04 10 54 diacylglycerol binding 
43548 1.82E-05 2.86E-04 4 6 phosphoinositide 3-kinase binding 
 
Supplementary Table 1c – Cellular Component; Motif 110: 
Total number of proteins in the network: 298; Number of all GO annotated Proteins: 9082 
GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
5912 1.36E-08 6.96E-07 12 45 adherens junction 
5925 1.56E-07 6.32E-06 9 28 focal adhesion 
31252 6.20E-07 1.96E-05 12 62 leading edge 
5924 5.64E-07 1.96E-05 9 32 cell-substrate adherens junction 
45121 1.07E-06 2.77E-05 11 54 membrane raft 
30055 9.95E-07 2.77E-05 9 34 cell-substrate junction 
48770 5.90E-06 1.29E-04 12 76 pigment granule 
42470 5.90E-06 1.29E-04 12 76 melanosome 
16323 1.16E-05 1.94E-04 12 81 basolateral plasma membrane 
5942 3.81E-05 5.15E-04 5 13 phosphoinositide 3-kinase complex 
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GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
1726 7.82E-05 1.01E-03 7 33 ruffle 
 
Supplementary Table 1d – Biological Process; Motif 4574: 
Total number of proteins in the network: 158; Number of all GO annotated Proteins: 8652 
GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
8286 1.08E-13 1.06E-11 11 24 insulin receptor signaling pathway 
7169 4.23E-13 3.86E-11 22 172 
transmembrane receptor protein 
tyrosine kinase signaling pathway 
7265 5.64E-09 2.67E-07 13 88 Ras protein signal transduction 
43066 8.43E-08 3.59E-06 17 195 negative regulation of apoptosis 
43069 9.79E-08 3.79E-06 17 197 
negative regulation of programmed cell 
death 
7159 2.32E-07 8.49E-06 6 16 leukocyte adhesion 
46777 5.93E-07 2.05E-05 8 41 
protein amino acid 
autophosphorylation 
16540 8.73E-07 2.74E-05 8 43 protein autoprocessing 
48009 3.59E-06 1.07E-04 4 7 
insulin-like growth factor receptor 
signaling pathway 
30856 3.59E-06 1.07E-04 4 7 
regulation of epithelial cell 
differentiation 
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GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
51049 6.04E-06 1.64E-04 12 135 regulation of transport 
 
Supplementary Table 1e – Molecular Function; Motif 4574: 
Total number of proteins in the network: 162; Number of all GO annotated Proteins: 9108 
GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
4715 1.18E-17 7.23E-16 15 36 
non-membrane spanning protein 
tyrosine kinase activity 
4713 3.30E-14 1.73E-12 22 156 protein tyrosine kinase activity 
4716 2.44E-08 5.27E-07 6 12 
receptor signaling protein tyrosine 
kinase activity 
32403 7.07E-08 1.37E-06 12 92 protein complex binding 
5158 6.74E-08 1.37E-06 7 22 insulin receptor binding 
4697 1.27E-07 2.32E-06 6 15 protein kinase C activity 
5057 3.98E-07 6.35E-06 13 128 receptor signaling protein activity 
43560 4.76E-07 7.06E-06 4 5 insulin receptor substrate binding 
43548 1.41E-06 1.91E-05 4 6 phosphoinositide 3-kinase binding 
19904 2.45E-06 3.21E-05 12 127 protein domain specific binding 
42169 8.71E-06 1.07E-04 5 17 SH2 domain binding 
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Supplementary Table 1f – Cellular Component; Motif 4574: 
Total number of proteins in the network: 159; Number of all GO annotated Proteins: 9082 
GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
45121 2.52E-08 1.17E-06 10 54 membrane raft 
5912 9.20E-07 3.06E-05 8 45 adherens junction 
16599 4.03E-06 1.04E-04 5 15 caveola 
5916 5.13E-05 7.97E-04 3 5 fascia adherens 
30018 7.90E-05 1.15E-03 4 14 Z disc 
31252 9.68E-05 1.33E-03 7 62 leading edge 
5925 1.10E-04 1.42E-03 5 28 focal adhesion 
5924 2.12E-04 2.47E-03 5 32 cell-substrate adherens junction 
30055 2.85E-04 3.02E-03 5 34 cell-substrate junction 
48770 3.51E-04 3.28E-03 7 76 pigment granule 
42470 3.51E-04 3.28E-03 7 76 melanosome 
 
Supplementary Table 1g – Biological Process; Motif 6558: 
Total number of proteins in the network: 90; Number of all GO annotated Proteins: 8652 
GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
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GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
8286 1.09E-12 5.72E-11 9 24 insulin receptor signaling pathway 
7169 1.42E-12 7.11E-11 17 172 
transmembrane receptor protein 
tyrosine kinase signaling pathway 
46777 7.22E-09 2.65E-07 8 41 
protein amino acid 
autophosphorylation 
43066 1.10E-08 3.79E-07 14 195 negative regulation of apoptosis 
16540 1.08E-08 3.79E-07 8 43 protein autoprocessing 
43069 1.26E-08 4.19E-07 14 197 
negative regulation of programmed cell 
death 
165 3.75E-07 9.85E-06 10 119 MAPKKK cascade 
48009 3.74E-07 9.85E-06 4 7 
insulin-like growth factor receptor 
signaling pathway 
30856 3.74E-07 9.85E-06 4 7 
regulation of epithelial cell 
differentiation 
43405 5.37E-07 1.36E-05 9 95 regulation of MAP kinase activity 
16485 7.74E-07 1.85E-05 8 73 protein processing 
 
Supplementary Table 1h – Molecular Function; Motif 6558: 
Total number of proteins in the network: 95; Number of all GO annotated Proteins: 9108 
GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
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GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
4715 3.23E-23 2.09E-21 16 36 
non-membrane spanning protein 
tyrosine kinase activity 
4713 7.86E-17 3.39E-15 20 156 protein tyrosine kinase activity 
5057 5.93E-10 9.03E-09 13 128 receptor signaling protein activity 
4716 9.65E-10 1.39E-08 6 12 
receptor signaling protein tyrosine 
kinase activity 
4697 5.09E-09 6.28E-08 6 15 protein kinase C activity 
19904 6.56E-09 7.72E-08 12 127 protein domain specific binding 
43560 5.51E-08 5.95E-07 4 5 insulin receptor substrate binding 
19992 7.29E-08 7.56E-07 8 54 diacylglycerol binding 
42169 6.22E-07 6.20E-06 5 17 SH2 domain binding 
5158 2.54E-06 2.35E-05 5 22 insulin receptor binding 
4715 3.23E-23 2.09E-21 16 36 
insulin-like growth factor receptor 
binding 
 
Supplementary Table 1i – Cellular Component; Motif 6558: 
Total number of proteins in the network: 92; Number of all GO annotated Proteins: 9082 
GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
45121 1.04E-06 5.78E-05 7 54 membrane raft 
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GO ID p-value 
Corrected 
p-value 
RN NPGT Description of GO Term 
16599 1.24E-05 4.10E-04 4 15 caveola 
5912 8.48E-05 2.17E-03 5 45 adherens junction 
31252 3.92E-04 8.14E-03 5 62 leading edge 
30877 6.01E-04 1.11E-02 2 4 beta-catenin destruction complex 
5916 9.95E-04 1.27E-02 2 5 fascia adherens 
16323 1.34E-03 1.58E-02 5 81 basolateral plasma membrane 
5925 2.74E-03 2.53E-02 3 28 focal adhesion 
5924 4.03E-03 3.52E-02 3 32 cell-substrate adherens junction 
30027 5.21E-03 3.97E-02 3 35 lamellipodium 
30055 4.80E-03 3.97E-02 3 34 cell-substrate junction 
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8 Appendix 1 - PlateletWeb user guide 
(This information is also published on Blood journal and can be found at Boyanova et. al 
(Boyanova, Nilla et al. 2012)). 
1. Introduction 
 
1.1  Using the PlateletWeb knowledge base 
PlateletWeb is a bioinformatical knowledge base covering the platelet proteome, 
transcriptome and interactome. By combining data of published platelet proteome and 
transcriptome studies with comprehensive protein-protein interaction data a first model of 
the platelet interactome has been derived. PlateletWeb makes this platelet interactome 
accessible to all researchers and allows an easy navigation through the web of platelet 
interactions. Additional information about the type of evidence (proteome, transcriptome 
or both) for each protein is provided. Based on the data of a recent phosphoproteome study 
the type of phosphorylation (serine/threonine, tyrosine) is indicated by an icon on the right 
side.  
1.2  Search for a specific protein 
Searching for a specific protein is easy: Simply enter the name of the protein or a part of the 
name (at least three characters) into the search field and submit your query. You will obtain 
a list of all proteins matching your query term. If the query term is too general it will 
produce too many (>50) matches. In this case no results will be returned and you will be 
asked to specify your search. 
1.3  Navigate through the platelet interactome and phosphoproteome 
The result list contains the name and a short description for each protein. The marker on 
the left side indicates whether the protein has been described on the level of the proteome, 
transcriptome or both. On the right hand side information about the phosphorylation status 
of each protein in unstimulated platelets is provided. Most importantly the link beneath the 
protein description displays the number of interaction partners in the platelet. By clicking 
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on this link you will obtain the list of interaction partners (all interactants or only platelet 
interactants). This allows you to navigate through the entire interactome network.  
 
2. Overview / Legend 
 
2.1  Platelet Proteins 
Icons describing the level of detection for each protein 
 
Proteome  
proteins found on the level of the platelet proteome 
 
SAGE  
proteins found on the level of the platelet transcriptome 
 
Both  
proteins found on the level of the platelet proteome as well as on the 
level of the transcriptome 
 
None  
proteins which have not been detected in the platelet 
 
2.2  Type of Experiment 
Icons describing the type of experiment which detects the interactions and 
phosphorylations of the proteins 
 
in vivo Experiment 
 
in vitro Experiment 
 
Yeast-two-hybrid (Y2H) Experiment 
 
2.3  Protein Phosphorylations 
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Icons describing the type of phosphorylations of each protein 
 
Experimental Platelet Phosphorylation S/T 
denotes platelet proteins phosphorylated on serine or/and threonine 
residues. The phosphosites are detected in platelets 
 
Experimental Platelet Phosphorylation Y 
 denotes platelet proteins phosphorylated on a tyrosine residue. The 
phosphosites are detected in platelets 
 
Experimental Platelet Phosphorylation S/T/Y  
denotes proteins phosphorylated on serine or/and threonine as well 
as tyrosine residues. The phosphosites are detected in platelets 
 
Experimental Human Phosphorylation S/T  
denotes proteins phosphorylated on serine or/and threonine residues. 
The phosphosites are detected in human cells 
 
Experimental Human Phosphorylation Y  
denotes proteins phosphorylated on a tyrosine residue. The 
phosphosites are detected in human cells 
 
Experimental Human Phosphorylation S/T/Y  
denotes proteins phosphorylated on serine or/and threonine as well 
as tyrosine residues. The phosphosites are detected in human cells 
 
2.4  Kinase Type 
Icons describing the type of kinase 
 
S/T Kinase  
denotes kinases that phosphorylate targets on serine or/and 
threonine residues 
 
Y Kinase  
denotes kinases that phosphorylate targets on tyrosine residues 
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S/T/Y Kinase  
denotes kinases that phosphorylate targets on serine or/and 
threonine as well as tyrosine residues 
 
2.5  Phosphatases 
Icons describing the Phosphatase 
 
Phosphatase  
denotes manually curated protein phosphotases 
 
2.6  Sources of Information 




denotes HPRD (Human Protein Reference Database) as the source of 
phosphorylation information  
 
PhosphoSite 
denotes PhosphoSite as the source of phosphorylation information  
 
NetworKIN  
denotes NetworKIN as the source of kinase predictions for 
experimental platelet phosphorylations 
 
2.7  Interaction Type 
Icons describing the Interaction type of the proteins 
 
Protein-protein interaction  
denotes interactions between proteins based on the NCBI dataset 





denotes phosphorylation reactions (kinases) derived from 
annotations in the HPRD and PhosphoSite databases  
 
Kinase predictions  
denotes phosphorylation reactions for kinases predicted by 
NetworKIN for experimental platelet phosphorylations 
 
Dephosphorylation  
denotes dephosphorylation reactions (phosphatases) derived from 
annotations in the HPRD database  
 
3. Where do I begin? 
PlateletWeb is a comprehensive systems biology tool, which allows a thorough analysis of 
HUMAN platelet and non-platelet proteins, their interactions, phosphorylation state and 
physical characteristics. The database contains validated experimental data on the platelet 
proteome and phosphoproteome, along with literature-derived information from HPRD 
(Human Protein Database Version 9.0). It is the first database of its kind, which gives the 
opportunity for extracting interactive subnetworks of proteins on a platelet and non-
platelet level. The user can choose between regular search of a specific protein of interest 
OR advanced search providing detailed information. 
 
Search  
In the search field on the left side of the window, just type in 
the name of the protein you are interested in and click on the 
"SUBMIT" button in order to get the protein related 
information. 
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This retrieves the list of proteins matching your search term. In our example, our search 
term is "VASP" and so we got the proteins matching VASP as output. 
 
Click on "platelet interacting proteins" to view the list of platelet interactions (In the 
picture, a subset of the proteins are shown).  
Alternatively, you can also click on "Total interacting proteins" for the complete list of 
interactions with this protein. 
 
 
To view in picture format: 
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On the top of the interactions page, you will find the link “To View in Network format, click 
here” which leads to the graphical representation of all retrieved interactions with the 
searched protein. 
What Next: Using the links “Please click here to download the file in pdf format” and “Click 
here to download the compressed file for Cytoscape” you can either view and save the 
image in the pdf (Adobe Reader) format or alternatively download the information to view 
in Cytoscape.  
Finally, 
As we can see, just by providing the name of the protein, one can easily navigate through all 
its interactions, get the complete description, view and/or download the network graph 
associated with it. Apart from this, there is always the possibility of searching for proteins 
with their physical characteristics, (using advanced search), download the subnetwork for a 
specific set of proteins (Cytoscape Download), and retrieve the complete information about 
their phosphorylation state, and if the proteins are kinases, their phosphorylation targets. 
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4. Description of Protein 
Once the protein's name is entered in the search field, a list of proteins matching the search 
term appears. By clicking on the protein's name in the list, the user can then open the page 
containing its description. This page includes information about the protein’s approved 
symbol, its multiple identifiers, the study and the fraction where the protein has been 
detected, its phosphorylation sites and alternative names. It also contains additional protein 
characteristics such as protein domains and motifs, Gene Ontology (GO) terms and 
predictions for transmembrane domains along with drugs and genetic diseases associated 
with the protein. 
 
In the special case of kinases, it is possible to examine all phosphorylation targets of a 
specific kinase and link to the targets' description directly. 




A.  General information about the protein 
The protein detection level along with its phosphorylated residues is presented. 
 
B. Total Interacting Proteins / Platelet Interacting Proteins 
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proteins and network view. 
 
C. Platelet Evidence 
Clicking on this link would provide a list of proteome studies, in which the protein was 
detected. Furthermore, it contains information about the cellular compartment of the 
protein along with a link to the study. The studies are divided into 2 groups, proteome 
data and database/SAGE source information. Additionally, the studies are categorized 
according to the cell fraction of the protein and the number of appearances in each 
fraction is displayed. 
 
D. Summary 
A short description of the protein and its functions is presented along with the links to 
PubMed. 
 
E. Nomenclature / Alternative Names 
Other names assigned to the protein. 
 
F. Approved Symbol 
This is the HUGO approved Symbol of the protein. 
 
G. (De-) Phosphorylations 
Total phosphorylations, divided into human phosphorylation sites and platelet 
phosphorylation sites. 
(see Section 5 for additional information) 
 
H. Phosphorylation Targets 
Kinases and Phosphatases are provided with a list of all their platelet and human 
substrates. 
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I. Domains and Motifs 
All domains and motifs of the protein are listed with a short abbreviation of the domain 
name and a complete domain description where available. 
 
J. Gene Ontology 
Full listing of all GO annotations of the protein. Further accessible are the GO terms, 
which contain at least 1 but not more than 150 platelet proteins. A link to all related 
children terms is displayed next to each of the protein's GO terms. 
 
K. KEGG Information 
Information about KEGG enzyme classification (for enzymes), orthology along with 
graphical presentation of pathways containing the platelet proteins (in yellow). 
 
L. Protein Physical Characteristics 
Isoform-specific information about the physical properties of the protein. Further 
details on the protein's molecular weight, isoform accession, its length, isoelectric point 
and the protein sequence in a downloadable FASTA format can be accessed. 
 
M. Associated Drugs (DrugBank Associations) 
All drugs are listed with their corresponding accession number for DrugBank. Clicking 
on the link "(db)" retrieves the DrugBank webpage with detailed information about the 
drug. 
 
N. Associated Genetic Diseases 
The "(Pd)" link next to each genetic disease term navigates to the PubMed information 
source. 
 
O. Predicted Transmembrane Domains 
Information on the number of predicted transmembrane domains for each isoform of 
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the protein is shown here. 
 
P. Additional Identifiers 
External links associated to the protein - identifiers from HPRD, NCBI gene id, OMIM id 




5. Phosphorylation and Kinase information 






147 | P a g e  
 
Clicking on the "(De-) Phosphorylations" link retrieves a list of all phosphorylated and de-
phosphorylated residues and their position in the protein's sequence. It is also possible to 
view the human (de-) phosphorylations and platelet phosphorylations individually. 
 
Underneath this information, you can find the isoforms in which the site is identified. 
Further down within the same phosphosite, one can find the phosphorylated motif 
sequence with the site highlighted in the middle. Additionally, the phosphorylating kinase 
(if available) is shown next to it. The source of phosphorylation information is presented 
under Reference. For kinase predictions on platelet phosphorylation sites the reference is 
given as NetworKIN (prediction algorithm). For all data from literature, the reference is 
either PhosphoSite or HPRD (Source: PubMed). Finally, each phosphorylation is presented 
with the type of experiment used for its detection. For some of the experimentally validated 
phosphorylations, there is a NetworKIN kinase prediction displayed on the description page 
of the protein. The HPRD-derived kinase-substrate pairs are also listed, but are not 
necessarily proven to play a role in platelets specifically. Still, it is a strong indication if both 
the kinase and its target protein are found in platelets and the target is phosphorylated. 
 
6. Advanced Search Features 
The advanced search features allow combining different search options into a more 
complex search with an emphasis on platelet proteins to obtain more specific results. 
 
6.1  Keyword search  
As an example, the search term “rheumatoid arthritis” reveals 27 total human proteins of 
which 10 are identified in platelets.  
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6.2  Physical property search 
Search for proteins in a particular range according to their molecular weight, isoelectric 






Note: Both results are SRC, however they belong to two different isoforms. It is possible to 
further navigate to the protein description page and the interactions and phosphorylations 
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6.3  Gene ontology Search 
Query: 




6.4  Combination search  
A combination of functional enrichment, protein domains and the detection level along with 
the phosphorylation information. This search option is very useful for a given biological 
question, for example connected to platelet activatory (or inhibitory) processes. 
Query: As an example, a search can be performed identifying hemostasic proteins, which 
bind tyrosine phosphorylated residues and therefore contain an SH2 domain and are 
additionally phosphorylated on a serine or a threonine residue, detected in a platelet 
proteome experiment. 
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6.5  Drug search 
Query: 
Search the drug name “clopidogrel” for its drug targets reveals,  
Result: 
 
The DrugBank source page can be accessed from the link in the resulting panel (Drug ID: 
DB00758). 
 
6.6  Pathway search 
Query: 
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6.7  Subnetwork extraction 
The "Extract subnetwork" option in the advanced search is introduced for the analysis of a 
set of proteins. The aim of this feature is to extract networks of interest from PlateletWeb 
and to visualize the interactions in a group of pre-selected proteins. The names of the 
proteins are entered in the search field, separated by a tab or comma. Click on the submit 
button to go to the next step. 
The resulting list of proteins is supplemented by a list of similar names in case proteins 
were not found in the search. Non-platelet proteins can also be added and analyzed. If the 
proper list of proteins is already available, the user can now choose between a graphical 
presentation of the constructed network and a list of interactions given in a text-format.  
By clicking on the "Network format" the network appears on the screen, depicting the 
proteins as nodes and the interactions between them as edges. All interactions and 
phosphorylation states are color and shape coded in the final result. 
Additionally, an option for network download is available by saving the network in a pdf 
file. 
 
If the user prefers extracting the data and creating a visualization with Cytoscape, there is a 
compressed Cytoscape file available for download. It contains a .sif file of the extracted 
interactome network, as well as edge and node attributes files (.eda, .noa), which can be 
added into Cytoscape to visualize specific features of the network. 
The edge attribute file contains the phosphorylation sites for each phosphorylated protein 
and the node attribute files include information about the node itself: name of the protein, 
whether the protein is a "kinase or not", whether it is "phosphorylated or not" etc.  
An easy option is to save the file on the desktop and then extract the folders. The 
visualization characteristics and legends are contained in the .props file in the folder 
"properties".  




Steps for importing the files into Cytoscape: 
File -> Import -> Network (multiple file types) -> .sif file from tmp folder 
File -> Import -> Node attributes -> .noa files from tmp folder 
File -> Import -> Edge attributes -> .eda files from tmp folder 
File -> Import -> Vizmap property file -> cytoscapevisuals.props from properties folder 
In order to view the optimal network in Cytoscape, select Layout -> yFiles -> Organic. The 
final version of the created network should be visible and available for further analysis.  
Query: 
ITGB3, SRC, CIB1, AKT1, PDK2, PPP2CA, BMPR1B, PDHX 
Result: 
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